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ABSTRACT 
The thesis presented here describes the steps that were taken in an attempt to solve the 
protein structure of MenD via molecular replacement and multiple wavelength anomalous 
dispersion. The introduction provides background on menaquinone biosynthesis and the role of 
MenD in this metabolic pathway. Also, a detailed discussion of the DC Family of enzymes, a 
subgroup of ThDP dependent enzymes, which MenD is a part of, is included.  
Utilizing various software packages a 1.9 Å data set was processed and analyzed in an 
attempt to provide a molecular replacement result. When molecular replacement was deemed 
incapable of solving the phase problem of the data set, the production of SeMet protein was 
attempted to allow for MAD phasing.  
A homology model of MenD was produced using the program Modeller with 
benzaldehyde lyase as a template. A structure based sequence alignment was done with all DC 
Family enzymes with structures published. Then a second structure based sequence alignment 
was done to compare the same set to the Modeller model.  This was done to gain a deeper 
understanding of MenD and how it interacts with its cofactors ThDP and Mg2+. Furthermore, 
these results were used to implicate potential active site residues.   
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CHAPTER 1: INTRODUCTION 
 
1.1 Menaquinones (Vitamin K2) 
 Menaquinones (Vitamin K2) are a group of compounds that contain a common 
naphthoquinone ring structure with a variable number of isoprenoid residues attached to the 3- 
position. They are generally referred to as MK-n, where n is the number of isoprenoid residues 
attached (Figure 1.1). Menaquinones are produced by certain bacteria, including Mycobacterium 
tuberculosis and Bacillus subtilis, for utilization as an electron shuttle within the electron 
transport chain (Bishop 1962; Truglio 2003).  
 Humans cannot synthesize Vitamin K2 and as such it must be obtained in our diet or from 
bacteria present within our intestine, such as Escherichia coli (Bentley 1982). Vitamin K2 plays 
an essential role as a cofactor in the carboxylation of glutamate from a variety of proteins known 
as Vitamin K dependent enzymes (VKD’s). VKD’s are now known to be present in almost all 
human tissues and are also required within bacteria. Among the many roles VKD’s serve, they 
have been shown to be required for the processes of bone mineralization (Weber 2001), blood 
coagulation (Vermeer 2001), apoptosis (Cheng 2003), signal transduction (Kulman 1997; 
Kulman 2001), growth control (Ni 1998), phagocytosis (Hall 2001; Hall 2002) and chemotaxis 
(Fridell 1998). It has also been proven that the medicinal provision of menatetrenone, MK-4, 
improves bone mineral density in osteoporosis patients (Shiraki 2000). 
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1.2 Menaquinone Biosynthetic Pathway 
 The biosynthesis of menaquinones within E. coli has been studied thoroughly 
(Meganathan 2001). Synthesis of menaquinones is performed by various enzymes encoded by 
the menaquinone operon, or as it is sometimes referred to, the men gene cluster (Figure 1.2). 
Within this gene cluster are six open reading frames which encode six enzymes named MenB 
through MenF and yfbB respectively. 
OH
OH
MK-2
      
OH
OH
3
MK-4
       
Figure 1.1 - Menaquinone chemical structures MK-2 and MK-4 showing the variable number of 
isoprenoid residues 
Figure 1.2 - The men operon in E. coli K12. The six enzymes MenB, MenC, MenD, MenE, 
MenF and yfbB (MenH) are responsible for the first six steps of the menaquinone pathway. The 
figure indicates that the MenD gene is approximately 1.7 kilo base pairs (Ecogene Webpage). 
 These six enzymes encompass a large portion of the molecular machinery required for 
the conversion of chorismate to menaquinones (Figure 1.3). The first reaction is the 
isomerization of the shikimate pathway product chorismate to isochorismate via the enzyme 
MenF. Although other enzymes produce isochorismate, MenF is thought to be the lone 
menaquinone pathway-specific isochorismate synthase (Daruwala 1996). It was understood that 
the subsequent reaction is the conversion of the MenF product isochorismate to (1R,6R)-2-
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succinyl-6-hydroxyl-2,4-cyclohexadiene-carboxylate (SHCHC) via MenD (SHCHC synthase), 
acting as both a decarboxylase and a lyase (Palaniappan 1992). However, it has been discovered 
recently that MenD produces 2-succinyl-5-enolpyruvyl-6-hydroxy-3-cyclohexene-1-carboxylic 
acid (SEPHCHC) from isochorismate rather than SHCHC (Jiang 2007). The formation of 
SHCHC from SEPHCHC is completed by MenH, which is also sometimes referred to as yfbB 
(Jiang 2008). The subsequent reaction in the pathway involves the conversion of SHCHC to o-
succinylbenzoate (OSB) via a dehydration reaction performed by MenC (o-succinylbenzoate 
synthase) (Sharma 1993). OSB is then linked to coenzyme A via MenE (o-succinylbenzoate-
CoA ligase) to produce o-succinylbenzoyl-CoA (OSB-CoA) (Sharma 1996) and then MenB 
(dihydroxynaphthoic acid synthetase) performs a ring closing reaction to produce the 
naphthoquinone ring structure seen in 1,4-dihydroxy-2-napthoyl-CoA (DHNA-CoA) (Sharma 
1992).  
As is noted in Figure 1.3, there is still an unknown enzymatic reaction that takes place 
within the pathway. It was previously believed that MenH converted DHNA-CoA to 1,4-
dihydroxyl-2-napthoate (DHNA) (Meganathan 2001).  However, this has been proven to not be 
the case and further research is required for a complete understanding of the menaquinone 
pathway (Jiang 2008). 
The differentiation of the various MK-n molecules is a result of various enzymes that act 
on DHNA. The products vary by the number of isoprenoid repeat units that are added to DHNA. 
The most commonly discussed, is the formation of MK-8 via MenA and MenG. The product of 
MenA is a demethylated form of MK-8 referred to as DMK-8 (Suvarna 1998) and finally MenG 
completes the menaquinone pathway by converting DMK-8 to MK-8 (KoikeTakeshita 1997). 
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Figure 1.3 - Menaquinone Biosynthetic Pathway   
1.3 MenD (SEPHCHC Synthase) 
  Until the early 1980’s it was believed that chorismate was directly converted to OSB via 
an enzymatic reaction involving 2-ketoglutarate (Meganathan 1981). However, further studies 
showed that isochorismate was involved in this reaction not chorismate, and also, a separate 
intermediate was formed via an enzymatic reaction (Bentley 1983; Meganathan 1983). This 
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intermediate was SHCHC and the enzyme was the product of the menD gene (Emmons 1985). 
The MenD reaction was thought to involve isochorismate and 2-ketoglutarate in the presence of 
thiamine diphosphate (ThDP) and a divalent cation such as Mg2+ to produce SHCHC, pyruvate 
and CO2. The rate of this reaction was monitored via a reduction in absorbance at 340 nm via a 
coupled assay with lactate dehydrogenase and NADH which reacts with the pyruvate product of 
the reaction (Bhasin 2003). 
Recently, it has been proposed that SHCHC is in fact not the product of the MenD 
reaction (Jiang 2007). This conclusion was made when it was uncovered that the consumption of 
isochorismate was not proportional to the formation of SHCHC. In acidic condition MenD 
consumes the isochorismate substrate but no SHCHC is formed, however, a new compound 
which was thought to be an intermediate, SEPHCHC, is formed (Figure 1.4). Under basic 
conditions (pH 7.4 – pH 10) the formation of SHCHC occurs at a slow rate (faster at higher pH 
values), even in the absence of MenD enzyme. The incorrect assignment of SHCHC as the 
product of MenD is most likely due to the spectrophotometric properties of SEPHCHC that make 
it undetectable by UV/Vis spectroscopy. It was not until separation and NMR analysis (Jiang 
2007) that the structure of this intermediate was confirmed. The rate of the enzymatic reaction 
was determined on the basis of isochorismate consumption via HPLC or UV/Vis spectrometry, 
both utilizing absorbance of photons emitted at 278 nm, the peak absorbance of isochorismate.  
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Figure 1.4 – Proposed MenD catalytic cycle for the formation of SEPHCHC.  
 
7 
 
 
1.4 Thiamine diphosphate dependent enzymes 
 Enzymes that use thiamine diphosphate (Figure 1.5) as a cofactor participate in many 
biosynthetic pathways. Among these many pathways are the key energy-providing pathways, 
such as the pentose phosphate pathway and the tricarboxylic acid cycle (Frank 2007). 
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P
O
O-
P O-
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Figure 1.5 – Thiamine diphosphate chemical structure which contains a pyrimidine ring, a 
thiazolium ring and a diphosphate group.  
 Some generalizations can be made in regards to the reactions that are occurring within 
ThDP-dependent enzymes. For instance, the enzymes can be classified into two general 
categories, those that perform decarboxylation reactions and those that perform non-
decarboxylating transferase-type reactions. It is notable that the substrates of the decarboxylation 
reactions are often 2-ketoacids and the transferase reactions often involve aldehydes (Frank 
2007). 
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Figure 1.6 - First half reactions for: A) generalized decarboxylase reaction B) generalized 
transferase reaction, note the similarities in the first half reaction of each 
 Both the decarboxylase and transferase reactions (Figure 1.6) are initiated by the ThDP 
moiety.  Upon binding of ThDP to the active site, an ylide is formed (Figure 1.7). Ylide 
formation allows for a nucleophilic attack from the C2 position of the thiazolium ring of ThDP 
on the substrate, enabling C-C bond lysis adjacent to a carbonyl in the substrate. The substrate is 
then covalently bound to the ThDP and forms an enamine intermediate with which a second 
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substrate can react (Figure 1.8). The nature of the bound substrate and the secondary substrate 
allows for the formation of a diverse library of products from ThDP dependent enzymes. 
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Figure 1.7 - Ylide formation – ThDP is activated for nucleophilic attack upon binding to ThDP-
dependent enzymes. An invariant glutamate acts as a proton-acceptor. An ylide is then formed as 
C2 of the thiazolium ring donates a proton to the pyrimidine ring.  
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Figure 1.8 - An enamine intermediate is formed following the removal of R4. The 
tautomerization allows for both nucleophilic attack by the carbanion intermediate on the 
secondary substrate and also stabilizes the intermediate in the enamine form.  
 The variation in substrates is due to differences seen with the active site residues of the 
enzymes within the family. However, the conserved binding of a divalent cation, the ThDP 
moiety and the subsequent formation of the enamine can be viewed as evidence of evolution 
from a common ancestral enzyme (Frank 2007).  
 Transketolase (TK, Figure 1.9) (Lindqvist 1994) was the first ThDP dependent enzyme 
with a published crystal structure. Since this finding, the structural models of many ThDP 
dependent enzymes have been determined via crystallographic methods. These structural models, 
along with structure-based sequence alignments of known structures and also sequence 
alignments of unknown structures, has allowed for the classification of ThDP dependent 
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enzymes into five separate families (Duggleby 2006). The first family is the transketolase family, 
which comprises enzymes such as dihydroxyacetone synthase and transketolase itself. Another is 
the oxidoreductase family, which includes enzymes such as pyruvate:ferredoxin oxidoreductase. 
Two of the other families are the 2-ketoacid dehydrogenases (K1 and K2). The K1 and K2 
enzymes are multienzyme complexes such as the pyruvate dehydrogenase complex and the 
branched-chain 2-ketoacid dehydrogenase E1.  
 
Figure 1.9 - Transketolase dimer, RCSB protein accession (PDB Code: 1TKB). ThDP is shown 
as spheres each monomer is shown in blue and green respectively. The overlap of the two 
monomers creates two equivalent active sites at the dimer interfaces. 
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 The final family designation is the decarboxylase family (DC family) where the common 
reaction includes the decarboxylation of a 2-ketoacid. The enzymes in this family that have had 
X-ray crystal structures elucidated include benzaldehyde lyase (BAL) (Mosbacher 2005), 
acetolactate synthase (ALS) (Pang 2004), acetohydroxy acid synthase (AHAS) (Pang 2002), 
indole pyruvate decarboxylase (IPDC) (Schutz 2003), benzoylformate decarboxylase (BFD) 
(Hasson 1998), carboxyethyl arginine synthase (CEAS) (Caines 2004), pyruvate oxidase (POX) 
(Muller 1994), oxalyl-CoA decarboxylase (OCDC) (Berthold 2007), and pyruvate decarboxylase 
(PDC) from both S. cerevisiae (Arjunan 1996) and Z. mobilis (Dobritzsch 1998). MenD is also a 
member of this ThDP-dependent decarboxylase family of enzymes (Duggleby 2006) and as such 
this family will be discussed in detail.  
Within the DC family a common domain arrangement is seen in each monomeric subunit 
of the enzyme (Figure 1.10). All of the monomer subunits of these enzymes contain three 
domains that are similar in size. The three domains can be referred to as the N-terminal 
pyrimidine binding domain (Pyr domain), the middle domain, and the C-terminal diphosphate-
binding domain (PP domain). Each of the domains contains a core composed of five or six 
parallel β-sheets, with each β-sheet linked by an α-helix forming a α/β-type supersecondary fold 
that resembles a Rossmann fold (Muller 1993). Despite the similarities seen with the three 
domains with regard to fold, only the Pyr and PP domains are involved in catalysis. All enzymes 
within the DC family exist as a dimer or a tetramer (dimer of dimers), with two or four active 
sites, respectively. The Pyr domain from one monomer and the PP domain of the second 
monomer come together to form one of the active sites on the enzyme. The active site cleft 
 formed by this association differs from enzyme to enzyme altering the accessibility of the bulk 
solvent, ThDP, and substrates to the active site.
Figure 1.10 - Domain organization of ThDP 
a varied number of parallel 
supersecondary fold. The N-
domain is shown at the bottom left 
(orange and red). Mg2+ is indicated by a salmon colored
image is a monomer subunit of benzoylformate decarboxylase (RCSB Protein Accession: 1BFD)
It has recently been discussed that ThDP dependent enzymes function as a dimer of non
equivalent active sites (Frank 2007)
equivalence of the active sites and the nature of the substrate and cofactor within it were found to 
be different in the crystal structure of transketolase
accounted for by the belief that a proton shuttle exists between the two aminopyrimid
 
dependent enzymes. Three domains are shown with 
β-sheets, each linked by an α-helix forming a 
terminal PYR domain is on the middle right
(green/yellow) and the PP domain is shown in the top left
 sphere and ThDP is shown in gray. The 
. This was first thought to be a possibility when non
 (Lindqvist 1994). This non
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ThDP in the two active sites. The distance has been approximated to be nearly 20 Å between the 
two ThDP molecules and there exists a cavity filled with hydrogen bonded water molecules and 
acidic aspartate and glutamate residues (Figure 1.11). This network of hydrogen bonds allows for 
communication, or a bridge, between the two cofactors.  
Both the Pyr and the PP domain are involved in the binding of the cofactors and the 
catalytic reaction. The Pyr domain provides a hydrophobic cleft for binding the pyrimidine ring 
of ThDP. The structural and electronic environment of the enzyme active site induces the V 
conformation of ThDP, placing the N4´ atom of the pyrimidine moiety proximal to the C2 atom 
of the thiazolium ring (Frank 2007). There also exists an invariant glutamate residue within the 
Pyr domain that interacts with N1´ atom of pyrimidine ring of ThDP. This glutamate residue 
causes the induction of the 1´,4´-imino tautomer of the ThDP moiety.  When ThDP is in this 
tautomeric conformation the lone pair of electrons on the imino group of the aminopyrimidine 
ring is adjacent to the C2 atom of the thiazolium ring. The result of this conformation change is a 
proton transfer that forms an ylide which can then activate the enzyme substrate via nucleophilic 
attack (Figure 1.7).  
 The PP domain is primarily involved in the binding of the diphosphate portion of the 
ThDP molecule and Mg2+. This interaction primarily relies on a structural motif / sequence 
fingerprint GDG-(X)24-NN and the resultant coordination between the interactions with Mg2+ 
and the diphosphate moiety within the active site. The interactions made by the residues within 
this motif and Mg2+ involve the aspartate side chain oxygen atoms, the main chain carbonyl of 
the first glycine residue, the side chain of the second asparagine, as well as coordination with a 
water molecule (Figure 1.12).  
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Figure 1.11 - Catalytic Duality, active site non-equivalence and the 20 Ǻ Tunnel. 1) The electron 
shuttle through the 20 Ǻ Tunnel between non-equivalent active sites from active site one to 
active site two when ThDP binds. 2) ThDP ylide is formed within active site one while active 
site two is deactivated following the electron shuttle. 3) Reaction with substrate in active site one 
results in a shuttle of electrons back through the tunnel to active site two. 4) Enamine formation 
in active site one and ylide formation in active site two  
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Figure 1.12 – Superimposition of ThDP moieties and GDG-(X24)-NN binding motifs from 
benzaldehyde lyase (Blue - PDB Code: 2AGO), carboxyethyl arginine synthase (Green – PDB 
Code: 1UPA) and indolepyruvate decarboxylase (Red – PDB code: 1OVM). The Mg2+ ion 
(shown in magenta) was added manually to indicate its approximate expected location.  
 As stated earlier, the middle domain appears to have no involvement in the catalytic 
reaction associated with the enzyme. It also has very little involvement in the dimer interface 
interactions of the enzyme and only minimal involvement in dimer-dimer interactions seen in 
tetrameric crystal structures that have been determined. It is therefore thought that this domain 
exists as a relic of evolution which was required for nucleotide binding (Duggleby 2006). Within 
POX and AHAS the middle domain is arranged such that flavin adenine dinucleotide (FAD) can 
be accommodated (Pang 2002, Muller 1993). Within the enzyme OCDC the middle domain 
allows for the binding of the large oxalyl-coenzyme-A substrate (Berthold 2007).  
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1.5 Enzymes of the DC Family 
1.5.1 DC Family Enzymes that Utilize H+ as a Secondary Substrate and Have a Pair of 
Histidine Residues Required for Catalysis 
Four of the ten DC family enzymes with structures elucidated share very common 
catalytic features. These enzymes are pyruvate decarboxylase from both Z. mobilis (ZmPDC) 
(Dobritsch 1998) and S. cerevisiae (ScPDC) (Arjunan 1996), indolepyruvate decarboxylase 
(IPDC) (Schutz 2003) and benzoylformate decarboxylase (BFD) (Hasson 1998).  
Within this subgroup of the DC family, the primary substrates that undergo nucleophilic 
attack from the ThDP ylide are all 2-ketoacids. Also, each of the four enzymes catalyzes non-
oxidative decarboxylation reactions of these 2-ketoacid substrates (ScPDC Figure 1.13, ZmPDC 
Figure 1.15, IPDC Figure 1.17 and BFD Figure 1.19). Subsequently, the product is formed with 
the addition of a proton to the decarboxylated intermediates. The reaction catalysis is believed to 
be primarily aided by the presence of a pair of histidine residues within the active site (Schutz 
2003). Mutagenesis studies of these residues in ScPDC (Liu 2001) and ZmPDC (Schenk 1997) 
indicated that these residues were essential for catalysis. The histidine pair for each of the 
enzymes is as follows: ZmPDC (His113, His 114), ScPDC (His114, His115), IPDC (His115, 
His116), and BFD (His70, His281). It is apparent that the histidine pair in BFD would not be 
indicated with a sequence alignment with the other enzymes. However, the histidines within 
BFD are positionally conserved within the active site (Hasson 1998). 
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A further similarity between these enzymes is seen with the binding of the common 
ThDP-dependent cofactors Mg2+ and ThDP. The GDG-X24-NN cofactor binding motif is 
completely conserved in all four enzymes.  
The first of these four structures to be elucidated was ScPDC (Figure 1.14). The structure 
was determined with single wavelength isomorphous replacement (SIR) using S. uvarum PDC 
crystals. The structure of ZmPDC (Figure 1.16) was then determined by utilizing the ScPDC 
model for molecular replacement. Similarily, the ZmPDC model was then used to determine the 
structure of IPDC (Figure 1.18) via molecular replacement. The structure of BFD (Figure 1.20) 
was determined with anomalous diffraction techniques utilizing mercury soaked crystals.  
There are strong indications of evolutionary divergence from a common ancestor when 
comparing the two PDC’s to IPDC. The PDC’s share a similar function and also a high sequence 
identity (31%) with IPDC. However, the most apparent difference that indicates this divergence 
is the presence of a hydrophobic pocket within the active site of IPDC, which is not present in 
ZmPDC (Schutz 2003). The active site cleft of IPDC is lined with hydrophobic residues such as 
alanine and leucine, however, in ZmPDC the enzyme active site is filled with large bulky 
hydrophobic side chains, such as tryptophan and tyrosine. These large residues prevent the 
binding of the larger indolepyruvate by reducing the active site volume of ZmPDC. The 
alteration of Trp392 within ZmPDC to Ala387 within IPDC, spatially allows for the binding of 
the larger indolepyruvate substrate to the active site of IPDC.   
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Figure 1.13 – The catalytic cycle of ScPDC and the general reaction that produces acetaldehyde 
from pyruvate via ScPDC catalysis
Figure 1.14 - ScPVD model (RCSB Protein Accession (PDB code): 1PVD) with ThDP shown as 
orange spheres. 
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Figure 1.17 - The catalytic cycle of 
acetaldehyde from indole-3-pyruvicacid via BFD catalysis
Figure 1.18 - IPDC model (PDB Code: 1OVM) with ThDP depicted as orange spheres
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Figure 1.19 - The catalytic cycle of BFD and the general reaction that produces benzaldehyde 
from benzylformate via BFD catalysis
Figure 1.20 – BFD Model (PDB Code: 1BFD). ThDP is depicted in orange as a stick model. The 
monomer is shown as presented within the protein data bank
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1.5.2 DC Family enzymes that utilize the same or similar primary and secondary substrates 
 Another subset of enzymes within the DC family exists where a secondary substrate 
similar to the primary substrate is attacked by the enamine/carbanion intermediate. Three 
enzymes with structures elucidated fall into this category: acetohydroxy acid synthase (AHAS) 
(Pang 2002), acetolactate synthase (ALS) (Pang 2004), and benzaldehyde lyase (BAL) 
(Mosbacher 2005).  
AHAS catalyzes the formation of acetohydroxy acid from pyruvate and 2-ketobutyrate 
(Figure 1.21). ALS forms acetolactate from two molecules of pyruvate (Figure 1.23), a reaction 
that AHAS can complete as well (Figure 1.21). Despite performing similar reactions the 
structures of the two enzymes are not identical. Structural differences within the active site make 
the binding of 2-ketobutyrate, which is seen in AHAS, sterically impossible in ALS.  
Furthermore, AHAS requires the binding of FAD as a cofactor whereas ALS does not utilize 
FAD or have an nucleotide binding site. Catalytically the enzymes are similar with both having a 
methionine, glutamine and lysine residue participating in catalysis (AHAS: Lys251, Gln 202 and 
Met582; ALS: Lys36, Gln420, Met 479) (Pang 2004). Sequence alignment of AHAS and ALS 
shows that the glutamine and lysine residues do not align and are in fact from different domains 
of the protein that form the active site. Although ALS and AHAS are thought to have a common 
ancestor (Bowen 1997) the two enzymes seem to have evolutionally converged to share similar 
functionality.   
Benzaldehyde lyase (BAL) catalyzes the stereospecific formation of R-benzoin from two 
benzaldehyde molecules, as well as the irreversible cleavage of R-benzoin (Figure 1.25). BAL 
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also accepts a variety of other substituted aromatic or aliphatic acyl-acceptors as substrates and 
has therefore been thought to be a potential tool for chemo-enzymatic synthesis of 
enantiomerically pure 2-hydroxy ketones (Demir 2001). For BAL both the forward and the 
reverse reactions are thought to utilize a water molecule which is hydrogen bonded to His29 and 
Gln119 to perform the catalytic reaction with the substrate.  
Sequence alignment and structural analysis indicate that BAL maintains the GDG-(X24)-
NN motif that is conserved for binding of ThDP and Mg2+. However, this is not the case for ALS 
and AHAS. ALS does not contain the NN portion of the GDG-(X24)-NN motif, but rather has a 
valine and aspartate residue in their stead. A mutation of the second asparagine in other ThDP 
enzymes has proven detrimental to ThDP binding. For example, in pyruvate decarboxylase from 
Z. mobilis the mutation of the asparagine residue (Asn467Asp) resulted in drastic loss of affinity 
for ThDP with the concentration of ThDP required for half saturation of the enzyme (S0.5) 
increasing by nearly three orders of magnitude (Candy 1998). For AHAS the binding motif is 
altered to GDA-(X24)-NN. This alteration is insignificant since the residue side chain is not 
involved in binding of ThDP or Mg2+ at this location but rather the main chain oxygen.  
The first structure within this subgroup of DC family enzymes to be solved was that of 
AHAS (Figure 1.22) (Pang 2002). The structure was solved via molecular replacement utilizing 
BFD as the search model. The same research group then published the structure of ALS (Figure 
1.24) two years later by using the AHAS catalytic residues for molecular replacement (Pang 
2004). Even with several DC family enzyme structures published, the structure of BAL was not 
solved with molecular replacement. Rather, a SeMet derivative of BAL was used to solve the 
structure (Figure 1.26) via multiple wavelength anomalous dispersion (MAD) (Mosbacher 2005). 
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Figure 1.21 - The catalytic cycle of AHAS. This enzyme can catalyze two separate reactions to 
produce 2-acetolactate and 2-aceto
Figure 1.22 - AHAS model (PDB Code: 1JSC).
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1.5.3 Other DC Family Enzymes with Elucidated Structures  
1.5.3.1 Carboxyethyl Arginine Synthase  
 Carboxyethyl arginine synthase catalyzes the dephosphorylation-carboligation reaction of 
D-glyceraldehyde and L-arginine to form N2-(2-carboxyethyl)arginine (Figure 1.28) (Khaleeli 
1999) The reaction is believed to follow the general transferase reaction mechanism with the 
aldehyde functional group of D-glyceraldehyde being activated, allowing for nucleophilic attack 
on L-arginine.  
The structure of CEAS was determined using multiple wavelength anomalous dispersion 
(MAD) using a SeMet mutant protein (Caines 2004). Based on the crystal structure with a 
sulphate ion bound to the active site in place of D-glyceraldehyde it is believed that this substrate 
is bound by two histidine residues (H120, H415) (Caines 2004). These two histidines do not 
participate in hydrogen donation or abstraction like is seen commonly with histidine pairs in the 
active site or ThDP dependent enzymes. It was assumed that much of the general acid-base 
catalysis is completed by ThDP itself (Khaleeli 1999). The structure of the enzyme indicates that 
the active site residues are not capable of general acid-base catalysis and that the 4´-amino group 
of ThDP plays an important role in catalysis (Caines 2004). 
 The primary sequence and structure of CEAS indicates that the GDG-(X24)-NN ThDP 
binding motif and the glutamate required for activation of ThDP are in place. The sulphate ion 
bound to CEAS is thought to be comparable to the phosphate of D-glyceraldehyde. Also, this 
sulphate is within proper distance from ThDP to allow for the four carbon bond links of D-
glyceraldehyde as well (Caines 2004). 
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1.5.3.2 Pyruvate Oxidase 
Pyruvate oxidase catalyzes both an oxidative decarboxylation and a phosphorylation 
reaction, in which, pyruvate is converted to acetylphosphate (Figure 1.26) (Gotz 1991). Unlike 
any of the other enzymes in the DC Family, POX utilizes a second cofactor, FAD, for oxidative 
alterations to the primary substrate (Figure 1.29). The enzyme still follows the general 
decarboxylation mechanism for ThDP dependent enzymes, yet it is the only ThDP dependent 
enzyme to utilize a phosphate molecule as a secondary substrate and also have a tertiary 
substrate, oxygen. The transfer of two electrons from oxyethyl-ThDP to FAD is facilitated by the 
presence of two phenylalanine residues from different domains (Phe121 and Phe479). FAD is 
then regenerated by oxygen to produce hydrogen peroxide. Subsequently, an inorganic 
phosphate group attacks the intermediate, releasing acetylphosphate and regenerating ThDP 
(Muller 1994). 
 The structure of POX (Figure 1.30) was determined using multiple isomorphous 
replacement (MIR) (Muller 1994). Phasing was initialized by utilizing data from seven heavy 
atom derivates and an initial electron density map refined to 3.5 Å was produced. The structure 
of the native enzyme was then determined to 2.1 Å resolution utilizing difference Fourier maps, 
iterative model building and refinement. 
 The conserved binding motif is altered to GDG-(X24)-TN within POX. Similar to ALS 
the primary interaction by the asparagine portion of the motif is altered. However, as is indicated 
in Figure 1.12 the first asparagines residue side chain is not directly involved in ThDP or Mg2+ 
binding. Therefore, this alteration is again not very substantial and as expected threonine is not 
implicated in ThDP binding (Muller 1994).  
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1.5.3.3 Oxalyl-CoA Decarboxylase 
Oxalyl-CoA decarboxylase (OCDC) catalyzes the non-oxidative decarboxylation of 
oxalyl-CoA to formyl-CoA (Figure 1.31). OCDC follows the general decarboxylation 
mechanism with H+ being the secondary substrate for the completion of the reaction. This is a 
similar mechanism seen with the PDC’s, IPDC and BFD.  
The structure of OCDC (Figure 1.32) was solved using molecular replacement techniques 
utilizing a polyalanine model of AHAS as the successful search model (Berthold 2005). Unlike 
the other enzymes which utilize H+ as a secondary substrate, OCDC does not have a pair of 
histidine residues present within the active site for catalysis. Rather OCDC contains a hydrogen 
bond network between a water molecule, the main chain nitrogen of Ile34, and the side chains of 
Tyr120 and Glu121.  These residues contribution to catalysis were confirmed with co-crystal 
structures containing substrate (Berthold 2007).   
There are some differences structurally for this enzyme when compared to other ThDP-
dependent enzymes.  As is quite evident from the reaction scheme in Figure 1.31, the substrate 
for this enzyme is considerably larger than most. The much larger substrate is accommodated by 
a binding pocket that bears resemblance to that seen in ThDP-dependent enzymes that contain 
FAD as a cofactor. Further differences are seen as OCDC also shows an allosteric effect from the 
addition of adenine diphosphate (ADP) (Berthold 2005).  Allostery is not noted within any of the 
other ThDP dependent enzymes. Also, the conserved ThDP binding motif is altered to GDS-
(X24)-NN within OCDC. Similar to AHAS this alteration is thought to be insignificant since the 
main chain carbonyl contributes to ThDP and Mg2+ binding and not the side chain.   
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1.6 MenD  
 As stated within section 1.4, MenD is also believed to be part of the DC family of 
enzymes (Duggleby 2006). However, the structure of E. coli MenD has not been elucidated and 
no theoretical model has been generated for this enzyme. This leaves a significant gap in the 
understanding of MenD’s structure-function relationship, catalytic processes and information 
necessary to develop inhibitors.  
Previous work done within the Palmer lab has implicated a variety of residues as required 
for catalysis. Mutagenesis and subsequent kinetic analysis has allowed for a variety of residues 
to be implicated as contributors to MenD catalysis, ThDP binding and activation, and also Mg2+ 
binding. Among them is the conserved glutamate residue, Glu55 in MenD, which is thought to 
be responsible for ThDP activation, since even conservative mutagenesis such as Glu55Asp 
results in complete loss of enzyme activity (Macova 2005).    
Another residue implicated is Ile418, which is thought to aid in the induction of the V-
conformation of ThDP upon binding. Again, a conservative mutation such as Ile418Leu results 
in near complete loss of enzymatic activity. One of the residues thought to be required for 
catalysis is Ser32, since mutagenesis has shown that the variant Ser32Asp results in complete 
loss of activity (Ho 2007). 
 A variety of other residues have been investigated with mutagenesis studies, including 
Asp442, which was implicated for Mg2+ binding within the ThDP-dependent enzyme binding 
motif. As well, Arg33, Arg395, Gln118 are all thought to participate in catalysis (Macova 2005). 
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The use of crystallographic methods will allow the determination of the actual interaction of 
all of these residues and their role in MenD catalysis. The information provided from structural 
analysis will provide a far more complete understanding of MenD, its associated mechanism, and 
its relation to various homologous enzymes. Furthermore, the elucidation of a protein structure 
will allow for the development of inhibitors for this enzyme that could potentially serve 
pharmaceutical purposes.        
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Chapter 2: Research Goals and Approach 
My primary research goal was to solve the phase problem from a MenD X-ray diffraction 
data set. Once the phase problem was solved, a structural model of MenD could be determined, 
refined and submitted to the protein data bank.  
In August of 2005, Edyta Sieminska grew crystals of MenD protein expressed from 
pMD14b. Two diffraction data sets were collected by Edyta at the Advanced Photon Source in 
Chicago later that month from two different crystal types. The first experiment produced a high 
resolution (1.9 Å) diffraction data set from native holoenzyme MenD crystals (co-crystallized 
with Mn2+ and ThDP). The second was a medium resolution (2.4 Å) diffraction data set collected 
from apoenzyme crystals.  
My work began with the analysis and processing of these data sets and the goals of this work 
were as follows: 
1) Process both diffraction data sets with MOSFLM and SCALA  
2) Determine which of the data sets is more suitable for molecular replacement strategies 
3) Solve the phase problem with molecular replacement software programs 
4) Produce/refine a structural model of MenD to aid in the understanding of the enzyme 
structure-function relationship.  
If these methods were unsuccessful, my research was to focus on the production of 
diffractable MenD protein crystals that contain seleno-methionine (SeMet) residues rather than 
methionine residues. This was thought to allow for the elucidation of the structure of MenD 
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using multiple wavelength anomalous dispersion (MAD) techniques with selenium acting as a 
heavy atom derivative. The steps that were outlined to achieve this goal are listed below: 
1) Clone the E. coli MenD gene into an appropriate vector for SeMet expression 
2) Show that the new construct expresses active MenD protein 
3) Provide experimental evidence that the new construct can be expressed in       
minimal media containing methionine 
4) Show that the MenD from the new construct can be purified using buffers           
containing a reducing agent such as TCEP 
5) Produce diffractable native crystals of MenD expressed from the new construct 
6) Produce SeMet derivative protein by expressing in minimal media devoid of           
methionine and containing SeMet 
7) Show that SeMet protein can be purified using the same procedure employed with native 
protein in the presence of TCEP  
8) Test level of inclusion of SeMet into protein using mass spectroscopy 
9) Produce diffraction quality crystals of SeMet derivative 
10) Collect full data set at three separate wavelengths at the Advanced Photon Source in 
Chicago for the SeMet derivative of MenD 
11) Solve the phase problem utilizing MAD computational methods to identify the location 
of SeMet residues and refine the structure  
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Chapter 3: Materials and Methods 
3.1 General  
 Luria-Bertani (LB) broth used for growth of bacterial cultures followed the Miller 
formulation, utilizing ten grams of BactoTM tryptone (Becton, Dickinson and Company), ten 
grams of sodium chloride (EMD Chemicals Inc.) and five grams of BactoTM yeast extract 
(Becton, Dickinson and Company) per liter of water.  Likewise, LB-agar followed the same 
formulation along with the addition of fifteen grams of granulated agar-agar (EM Science). The 
prepared solutions were then autoclaved prior to addition of ampicillin. Upon cooling to 50 oC 
the LB-agar solution had ampicillin added to it and then was poured into sterile polystyrene petri 
dishes (VWR) in twenty milliliter portions.   
3.2 Software Utilized 
 Molecular replacement was attempted with various software packages including AMoRe 
(Navaza 1994), Phaser (Read 2001) and MR BUMP (Keegan 2006). The data which was used 
for molecular replacement was integrated and scaled using MOSFLM (Leslie 1992) and SCALA 
(Weiss 2001). Polyalanine models were produced with the use of the MOLEMAN2 (Kleywegt 
1998). A MenD model was generated with the program Modeller (Fiser 2000) using 2AG0 as a 
reference model. Least squares analysis of the MenD model to 2AG0 was completed using 
LSQMAN (Kleywegt 1996). Structure based sequence alignments were performed using the 
online program FUGUE (Shi 2001) and the output is reformatted using ESPript (Gouet 1999). 
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PDB files are analyzed with Coot (Emsley 2004) and presented within this document using 
PyMol (DeLano 2002).  
3.3 Cloning Procedures 
 Primers were designed that could allow for the copying of the MenD gene from the 
pMD14b plasmid (developed from pET14b) via the polymerase chain reaction (PCR) and also 
included restriction sites that were appropriate for fusion into pQE80L. These primers were a 
forward BamHI primer with the sequence 5´ CCGCGCGGATCCCATATGC 3´ and the reverse 
KpnI primer with sequence 5´ GCAGCCGGTACCTCATAAATGGC 3´ (provided by Alpha 
DNA). A PxE 0.2 Thermocycler (Thermo Electron Corporation) was then used to perform a 
PCR. The PCR program utilized a 50 µL mixture containing 93 ng / µL pMD14b plasmid (93.4 
ng/ µL, 2.0 µL), 20 µM forward BamHI primer (1.0 µL), 20 µM reverse KpnI primer (1.0 µL), 
25 µM dNTP (0.4 µL), nuclease free double distilled water (39.6 µL), Taq polymerase (1.0 µL), 
and 10x PCR buffer (5.0 µL). An annealing temperature of 56 oC was decided upon given the 
provided melting point temperatures from Alpha DNA. The solution was first heated to 95 oC for 
two minutes to ensure melting of all plasmid DNA. The temperature was then dropped to 52 oC 
to ensure strong annealing of the primers to the strand and then the bound primers were extended 
by adjusting to the optimal Taq polymerase temperature of 72 oC for two minutes. The following 
cycle was then repeated thirty times: melting at 95 oC for thirty seconds, annealing at 56 oC for 
one minutes and then extension at 72 oC for the next two minutes (total time of 30 cycles was 
105 minutes). The solution was then placed at 72 oC for an additional ten minutes and then the 
temperature reduced to 4 oC until the system was shut down.  
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 The product of this reaction was then run on a 1% agarose gel and a band of the 
appropriate predicted size was identified on the gel with comparison to 1 Kb Plus DNA ladder 
(Invitrogen). This band was then excised and purified using a QIAquick gel extraction kit 
(Qiagen) using the outlined procedure in the provided manual. The purified DNA insert was then 
doubly cut with KpnI and BamHI using a solution containing 2.0 µL KpnI, 2.0 µL BamHI, 12.0 
µL of purified DNA, 2.0 µL of 10x Buffer and 2.0 µL of H2O. Similarly, pQE80L plasmid was 
cut with KpnI and BamHI. Nova Blue cells were then transformed with a ligation mixture using 
the heat shock method with a forty-five second exposure to a 42 oC bath with immediate return 
to an ice bath. The transformed cells were then plated on LB Amp+ plates with the most colonies 
occurring in solution prepared with a 5:1 ratio of cut insert DNA concentration to cut pQE80L 
DNA for the ligation.  
3.4 Sodium Dodecylsulphate Polyacrylamide Gel Electrophoresis (SDS-PAGE) 
 In the case of MenD, a 61.4 kilodalton (kDa) protein as a monomer, a 10% acrylamide 
gel was prepared. A 10% acrylamide gel allows for separation of proteins between twenty and 
eighty kDa. The gel was prepared with two components, a stacking gel solution and a separating 
gel solution, in accordance with a standard recipe (Table 2.1). 
Table 3.1 - SDS-PAGE gel preparation recipe for one gel (*APS must be made fresh) 
Component 10% Separating Gel Stacking Gel 
H20 3.55 mL 1.8 mL 
1.5M Tris (pH 8.8) 1.9 mL 0.315 mL 
40% Acrylamide mix 1.9 mL 0.315 mL 
10% SDS 75 μL 25 μL 
10% APS* 75 μL 25 μL 
TEMED 7.5 μL 2.5 μL 
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 Materials used to prepare these two solutions were all purchased from Sigma-Aldrich 
with the exception of ammonium persulphate, which was purchased from VWR International 
Ltd. The dual gel casting unit and associated parts was purchased from Hoefer Scientific.   
 In order to identify MenD on the acrylamide gel a molecular weight standard was also 
loaded (SigmaMarkerTM Low Range (M.W. 6,500-66,000)). The electrophoresis experiment was 
run at a constant voltage (220 V) until the tracking dye reached the bottom the gel. The gel was 
then removed from the casting unit and stained in coomassie brilliant blue (VWR Scientific). 
After staining is complete the gel is destained using two solutions, a fast destaining solution 
(30% methanol, 10% acetic acid), and a slow destaining solution (5% methanol, 7% acetic acid). 
Finally, the gel is dried on a gel drying film (VWR Scientific) using drying solution (40% 
methanol, 10% glycerol, 7.5% acetic acid).  
3.5 Expression Procedures 
3.5.1 Protein Expressed from pMD80L plasmid  
 Utilizing a single pMD80L transformed colony from a LBAmp-agar plate, a 10 mL LB 
broth culture was grown overnight at 37 oC in the presence of 100 µg/mL ampicillin. The next 
morning 1.0 mL of this solution was added to 1.0 L of autoclaved LB broth containing 1.0 mL of 
100 mg/mL ampicillin. The solution was then placed in an Orbit environ shaker at 225 rpm and 
the growth of cells was monitored with the progression of optical density at 600 nm (OD600) 
using a UV/Vis spectrometer. Upon obtaining a OD600 that falls in the range of 0.4 to 0.8, the 
temperature of the shaker was lowered to 30 oC and the cells were induced with 1.0 mL of 0.1 
mM isopropyl-beta-D-thiogalactopyranoside (IPTG). Following four hours of growth the cells 
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were harvested via centrifugation at 8000 rpm in a Beckman J2-HS centrifuge using a JLA 
10,500 rotor. 
 The pelleted cells were collected and then resuspended in cold lysis solution. A 25x lysis 
solution was composed of 25 mM DNase, 25 mM 4-(2-Aminoethyl) benzenesulfonyl fluoride 
hydrochloride (AEBSF), 1.4 mM lysozyme. 1.0 mL of this 25x lysis solution was added to 12.0 
mL of cells suspended in 12.0 mL of 50 mM Tris-HCl pH 7.8-7.9. The final concentration of 
Tris-HCl was thusly 25 mM and the lysis buffer was diluted to 1x. This mixture was kept cold in 
an ice bath or placed in a 4 oC fridge and mixed vigorously with a stir bar for thirty minutes.  
 Following completion of exposure to the lysis solution the cell solution was then 
sonicated with a Virtus Virsonic ultrasonic cell disruptor. Volumes greater than 35 mL used the 
larger probe, whereas smaller volumes used the micro-tip probe. The total time of sonication was 
three minutes with intervals set up to have the sonicator activated for two seconds and then 
deactivated for three seconds. The solution was kept on ice. The three minute total time was split 
into three one minute intervals with two minutes between each interval to allow the solution to 
cool.  
3.5.2 Seleno-methionine Protein Expressed from pMD80L 
 Expression of selenomethionine (SeMet) containing protein was accomplished with the 
utilization of an expression kit (MD045004-12L) provided by Medicilon. This kit utilizes 
methionine pathway inhibition to ensure high inclusion of SeMet and minimal amounts of 
methionine within the protein. The kit was used for the growth of a 1.0 L culture of SeMet 
protein. However, the procedure utilized for the inoculation stage did not follow the outlined 
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protocol. Instead, 10.0 mL of the cells were grown in the standard conditions for native 
production of pMD80L MenD for inoculation. The cells were then centrifuged at 15000 rpm in a 
Beckman J2-HS centrifuge containing a JA 25.50 rotor. The supernatant was then poured off and 
the pellet re-suspended in 10.0 mL of 1x M9 salts solution. The M9 solution used was prepared 
as a 10x solution containing 60.0 grams of Na2HPO4, 30.0 grams of KH2PO4, 10.0 grams of 
NH4Cl, 5.0 grams of NaCl and then double distilled water was added to a volume of one liter. 
This mixture was then autoclaved. The resuspended cells were then added to the expression kit 
as directed in a 10.0 mL aliquot.  
 The cells were grown to an OD600 of 1.2 and then the temperature of the solution was 
decreased to 20 oC prior to the addition of the inhibitor cocktail and the SeMet. The solution was 
then allowed to grow overnight (approximately twelve hour incubation) and was then harvested.  
3.6 Purification Procedures 
3.6.1 Purification of E. coli MenD From pMD80L Construct 
 The procedure utilized for the purification of the protein produced from the expression of 
pMD80L construct involved the utilization of a POROS MC-50 His-tag column. The purification 
was performed using a BIOCAD 700E perfusion chromatography workstation and an Advantec 
SF-2120 superfraction collector.  
 The first stage involved equilibration of the column using five column volumes of filtered 
water (40 mL / min), followed by ten column volume of 50 mM NiSO4 (10 mL / min) to charge 
the column, and subsequent washing with another five column volumes of water (40 mL / min).  
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 Prior to loading the column with protein sample the column was exposed to five column 
volumes of binding buffer.  A 1.0 L solution of the binding buffer contained 5 mM imidazole, 
0.5 M sodium chloride, 12.5% glycerol, and 20 mM Tris-HCl, pH 7.9. The final pH of the 
solution was then adjusted to pH 7.9 with the addition of 1 M NaOH.  
 Following equilibration of the column with binding buffer, 5.0 mL of the sample was 
injected onto the column by the BIOCAD and then the unbound protein was washed away with 
another five column volumes of binding buffer. The system then repeats the injection of another 
5.0 mL of protein sample and another washing with five column volumes of binding buffer.  
 Following the second injection the column is washed with ten column volumes (40 mL / 
minute) of wash buffer to elute non-specifically bound protein from the column. A 1.0 L solution 
of wash buffer contains 50 mM imidazole, 0.5 M sodium chloride, 20 mM Tris-HCl pH 7.9, and 
12.5% glycerol. The final pH of the solution was again adjusted to 7.9 with 1 M NaOH.  
 Upon completion of the wash stage the bound protein is eluted with a gradient from 
100% wash buffer to 100% elution buffer over fifteen column volumes at (40 mL / min). While 
the elution of the protein was occurring the Advantec SF-2120 superfraction collector was 
collecting 10 mL fractions (12 in total). A 1.0 L solution of the elution buffer contains 0.1M 
ethylenediamine tetraacetic acid (EDTA), along with 0.5 M sodium chloride, 20 mM Tris-HCl 
pH 7.9, and 12.5% glycerol. The final pH was once again adjusted to pH 7.9 with a large amount 
of NaOH in order for the EDTA to dissolve in solution (See Figure 4.14 for sample purification 
output). 
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 The column is cleaned for next usage with an additional five column volumes of elution 
buffer, as well as ten column volumes of each of 1.0 M HCl, 0.5 M NaOH and finally double 
distilled water. The entire column cleaning procedure is completed with a flow rate of 40 mL per 
minute.  
3.6.2 Purification of SeMet E. coli MenD  
 The purification procedure for the seleno-methionine derivative was the same as that for 
the wild-type pMD80L protein with a single alteration. Each of the binding, wash and elution 
buffers contained Tris(2-carboxyethyl) phosphine (TCEP) at a concentration of 2 mM. The 
addition of this compound was deemed necessary for the SeMet construct since the presence of a 
strong reducing agent ensure that the selenium within the protein does not become oxidized.  
3.7 Dialysis Procedures 
 Dialysis procedures were completed with the purified protein to remove residual 
components from the purification procedure. A three step dialysis procedure was carried out by 
placing the purified protein solution within Spectra/Por Dialysis Membrane (VWR Scientific) 
with a molecular weight cut off of 6-8 kDa. The dialysis solution was one liter in volume and 
varied slightly depending on the components included to have either holo or apo enzyme. In the 
case of the apoenzyme the solution consisted of 2 mM MgCl2, 150 mM NaCl, 50 mM Tris-HCl 
at pH 8.0 and 10% glycerol. For the holoenzyme the solution remained the same, however ThDP 
was also added to the mixture at a concentration of 100 µM. In the case of SeMet protein the 
addition of 2 mM TCEP was also required to ensure that the selenium was not being oxidized, as 
was the case with purification as well.  
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In the latter stages of this project it was discovered that the 10% glycerol was not 
necessary to be added to prevent protein precipitation. As such, future dialysis of the protein 
produced by the pQE80L construct can go without this component.   
To complete the dialysis, the protein solution was exposed to the first liter of solution 
placed in a 1000 mL graduated cylinder for a period of ninety minutes at 4 oC with moderate 
stirring. Following the first step the dialysis tubing was placed in the second liter of solution for a 
period of four hours at 4 oC , again with moderate stirring. The third step of the dialysis was left 
overnight under the same conditions in a third solution.    
3.8 Concentration Procedures 
 The resulting solution from the dialysis was concentrated in an Amicon Ultra centrifugal 
filter device with a 30,000 molecular weight cut off. A Sorvall Legend RT table top centrifuge 
was used at 3150 rpm in ten minute intervals until the concentration was complete. The filtrate 
was discarded, while the concentrated solution was always poured back into the mother liquor to 
ensure the protein concentration within the centrifuge device was not increasing to precipitating 
levels.   
3.9 Bradford Assay Analysis to Determine the Extinction Coefficient (ε) of MenD
 
 In order to ensure a fast and repeatable measurement of the numerical value of protein 
concentration an experiment to link the Bradford Assay to absorbance at 280 nm (A280) was 
performed. This was also done since it was found that the Bradford Assay used a larger volume 
of the purified and concentrated protein then the absorbance test would require.  
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 Beer’s Law, A280 = εbc, was utilized to determine the extinction coefficient (ε), where b = 
the path length of light through the sample, and c = concentration in units of mol/L (M). The 
protein concentration was found using a Bradford Assay. The pathlength (b) was the standard 
one centimeter. A reading of A280 was taken by first performing a blank/zero reading of one 
milliliter of pH 7.8 Tris-HCl buffer and then in a separate cuvette placing 10 µL of protein 
sample from the same batch of protein utilized for the Bradford Assay into 990 µL of pH 7.8 
Tris-HCl buffer.  From this information the extinction coefficient could be determined. Due to 
errors that commonly arise from the Bradford Assay the experiment was repeated ten-fold and 
utilizing a variety of protein concentrations to ensure that variable concentrations did not affect 
the result.  
 It was found that using 10 µL of protein solution and diluting it as described above that 
an A280 reading of 0.0983 translated to 10 mg/mL of protein.  Therefore, any protein sample 
could be analyzed using the following simple formula where Cstandard is equal to 10 mg/mL and         
A280, standard is equal to 0.0983.   
Cprotein = A280, protein * Cstandard / A280, standard 
3.10 Crystallization Procedures 
3.10.1 Sitting Drop Screening 
 Sitting drop crystallization experiments were set up at both room temperature and within 
a cold room (4 oC) using Nextal crystal screens supplied by Qiagen. The screens utilized for 
analysis include the Classics, Classics Lite, Cryos, Classics II, pH clear, and pH clear II, JCSG+, 
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PACT, Anions, Cations, PEG, PEG II, AmSO4, MPD and ComPAS. All of these were set up in 
96-well sitting drop trays using 100 µL of well solution, which was provided by the Nextal kits, 
and then utilizing 1.0 µL of well solution and 1.0 µL of protein solution. In some cases a 2:2 
ratio was utilized to provide a slight alteration to the surface area of the drop. The wells are 
covered with a transparent tape as quickly as possible to ensure minimal evaporation to the 
environment.  
3.10.2 Microbatch Screening 
 In the case of microbatch screening the Nextal screens provided by Qiagen were again 
utilized as was the case in the sitting drop experiments. Crystal plates were again set up in both 
the cold room (4 oC) and at room temperature (22 – 25 oC). However, in the case of this 
experiment seventy-two well microbatch plates were utilized. Therefore, it requires the use of 
two microbatch plates to do a single Nextal screen. In this experiment 1.0 µL of protein solution 
was mixed with 1.0 µL of well solution directly from the Nextal screen. The wells are then 
covered with Al’s oil (50% paraffin oil and 50% silicon oil) to ensure minimal evaporation to the 
environment. The mechanism of crystallization differs when comparing that of microbatch with 
sitting drop because the latter relies on active diffusion whereas microbatch simply relies on 
mixing.    
3.10.3 Hanging Drop and Optimization Methods 
 Crystal conditions that were found to produce crystals were optimized by creating a 
custom screen around that condition. For instance, if crystals were found in a well containing 0.1 
M sodium acetate pH 5.0 and 40% MPD as well as in a well containing 0.1 M sodium acetate pH 
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6.0 and 30% MPD. An optimization could be set up to test several conditions that vary the pH of 
the sodium acetate between 5.0 and 6.0 and the concentration of MPD between 30% and 40%.  
 The most used procedure for optimization was to utilize both hanging and sitting drop. 
The hanging drop method utilizes the same concept but is set up slightly differently and often has 
a larger volume of protein and precipitant mixed together. 3.0 µL or 5.0 µL of each the protein 
sample and precipitant were utilized rather than the 1:1 or 2:2 ratio that was often used with the 
sitting drop technique. With the larger volume often large crystals were formed using this 
technique. That being said, the size of the crystal does not determine how well it diffracts the 
incoming x-rays.  
3.11 Diffraction Procedures 
 Many of the crystals found within the screens and produced from optimization were 
tested for diffraction on the DX8 Proteum diffractometer at the Saskatchewan Structural Science 
Center at the University of Saskatchewan. Crystals were mounted on a loop and centered infront 
of the X-ray beam. Exposure times for diffraction were set at sixty seconds, the crystal was then 
rotated ninety degrees and exposed for an additional sixty seconds. For crystals that had some 
indication of a diffraction signal they were exposed a second time for a five minute interval at 
the angle that produced better results.  
 In all diffraction experiments, the crystals were not placed in a cryoprotectant since the 
exposure to X-ray beam was only one minute for each crystal. It is possible yet unlikely that the 
integrity of the crystals was compromised but all diffraction experiments were conducted with 
the same methods.  
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Chapter 4: Results and Discussion 
4.1 Computational Work   
 In August of 2005 two high resolution diffraction data sets of crystals from the pMD14 
construct of the enzyme were gathered by Edyta Sieminska. The two data sets were from an 
apoenzyme crystal and a holoenzyme crystal which was co-crystallized with both MenD 
cofactors; Mn2+ and ThDP.  The first work that was done by myself was the processing of the 
acquired data and the following attempts to solve the phase problem using this data set for 
molecular replacement (MR). Many different software packages were used for this analysis and 
results of each will be discussed briefly.  
4.1.1 MOSFLM and SCALA 
 The processing of the data sets was completed via the integration and scaling of the 
information provided by the diffraction images collected. This is done to determine the 
resolution limits of the images, the crystal mosaicity, the space group of the unit cell, the number 
of rejected reflections and the signal-to-noise ratio (I/σ) by sequentially using two separate 
software packages, MOSFLM (Leslie 1992) and SCALA (Weiss 2001).  
With the use of MOSFLM, the crystal mosaicity of the holoenzyme was found to be 0.42 
and the space group to be P212121 with the following dimensions: a = 106.686, b = 143.1776, c = 
156.9498. Utilizing SCALA to analyze the integrated data output from MOSFLM, it was found 
that the holoenzyme dataset was 97.3% complete at a resolution limit of 1.9 Å and a signal to 
noise ratio greater than 2.0 (Table 4.1A). The apoenzyme data indicated the same space group 
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with similar dimensions (a = 106.4761, b = 143.0784, c = 159.037) but had a higher mosaicity 
value of 0.51. The data for the apoenzyme was also only 68.3% complete at a resolution limit of 
2.4 Å, and indicating a signal to noise ratio greater than 2.0 (Table 4.1B).   
Table 4.1 - Output data from SCALA to determine the resolution limit. The first column of each 
table indicates the series of values of increasing resolution. The second column indicates a value 
of Rmerge; a value of 0.400 was utilized to select resolution limit with Rmerge. The third column 
indicates the signal to noise ratio (I/sigma); a value of 2.0 was utilized to select resolution limit 
with I/sigma. Table A shows the holoenzyme data; Table B shows the apoenzyme data  
   A      B 
Dmin  
(resolution (Å)) Rmrg I/σ 
5.06 0.021 26.5 
3.58 0.027 18 
2.92 0.036 16.1 
2.53 0.059 12.6 
2.26 0.091 8.1 
2.07 0.193 3.8 
1.91 0.353 2.7 
1.79 0.704 1.6 
1.69 1.143 0.9 
 
The output from SCALA is a reflection data file which is an encoded file containing the 
intensity of reflections. This file is developed with the specific purpose of being input for further 
analysis using a variety of other software programs used to solve the phase problem. The data for 
the holoenzyme was selected to be used for further analysis with molecular replacement 
programs since it had a higher resolution, higher percent completeness and less crystal mosaicity 
than the apoenzyme. 
 
.  
Dmin  
(resolution (Å))
 
Rmrg I/σ 
  5.55 0.024 21.1 
3.93 0.032 18.6 
3.21 0.052 13.3 
2.78 0.123 6.1 
2.48 0.302 2.4 
2.27 0.619 1.2 
2.10 1.51 0.5 
1.96 2.675 0.3 
1.85 7.813 0.1 
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4.1.2 MRBUMP 
 The first program that was attempted for molecular replacement was a novel software at 
the time called Molecular Replacement By Using Multiple Proteins (MRBUMP, Keegan 2006). 
MRBUMP requires nothing but a protein sequence and a reflection data file to perform a 
sophisticated and automated search for the best molecular replacement solution. It does this by 
performing a sequence alignment with all known proteins in the RCSB protein databank and then 
selecting those with the best alignment scores for further processing. The selected molecules then 
undergo molecular replacement and, if prompted to, a determined number of rounds of 
refinement.  
Utilizing MRBUMP to find a molecular replacement solution for MenD resulted in no hit 
protein sequences within the protein data bank. In 2007, many alterations were made to the 
MRBUMP software suite that allowed the user to alter the minimum sequence identity the 
program accepts. Unfortunately, even with the improvements to this programs interface and the 
ability to alter the program parameters, a suitable molecular replacement solution is still not 
provided by MRBUMP for MenD. The most common result of the usage of MRBUMP in this 
project was an error message that indicated that no structure within the PDB was sufficiently 
similar for the program to proceed.   
4.1.3 AMoRe 
 The second program that was utilized for molecular replacement was AMoRe (A 
Molecular Replacement program, Navaza 1994). This software performs a rotation and a 
translation function of the input model into the signal designated by the input reflection data file. 
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AMoRe then outputs how well the input model correlates to the signal present to give a 
correlation coefficient and an Rf value. An ideal solution will be one that has a high correlation 
coefficient and the lowest Rf value.  
Rf is a measure of model quality comparing |Fobs| and |Fcalc|: 
                         ∑ | |Fobs| - |Fcalc| | 
Rf =            --------------------------------- 
                         ∑ |Fobs| 
The measured structure-factor amplitude, (|Fobs|), is calculated from reflection intensities from 
the data set and |Fcalc| is the calculated amplitude from the model provided. An Rf value of 0.60 
(often displayed as 60 in AMoRe (as a percentage value)) indicates that the measured amplitudes 
are being compared to random amplitudes (Rhodes 2000). 
The correlation coefficient is an alternative mathematical comparison of the amplitude of 
the observed structure factor within the data and the calculated structure factors provided by the 
model. The scale used for the correlation coefficient within AMoRe is a percentage value from 
0-100 (Navaza 1994). 
The reflection data file produced by SCALA was utilized within AMoRe by comparing 
the data to seventeen enzyme coordinate files from the protein data bank to produce a molecular 
replacement solution. Along with these computational experiments being completed, polyalanine 
co-ordinate files of the same seventeen models were generated using MOLEMAN2 (Kleywegt 
1998) and analyzed with AMoRe.  The best result produced by AMoRe was with the model of 
yeast AHAS bound to an inhibitor tribenuron methyl (PDB code, 1T9A). For this model AMoRe 
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gave a peak Rf value of 54.3 and a second best Rf value of 55.1. The correlation coefficient (CC) 
showed a maximum value of 8.9 and a second best value of 8.4. These results were deemed the 
best because of the presence of a gap between the best and second best result for both the values 
of Rf and the correlation coefficient. The variance in top results for Rf and CC were not present 
in any of the other models analyzed by AMoRe. Such a gap can often be indicative of a result 
that is not just random alignment. A complete chart of the results obtained from all thirty-four 
models is seen in Table 4.2. None of these results were improved with stepwise refinement using 
Refmac5 (Murshudov 1997).  
The results produced using AMoRe were deemed insufficient for a structural solution and 
the software package was not used again for the remainder of the research project.   
4.1.4 PHASER  
 Although molecular replacement was unsuccessful using AMoRe, another software suite 
known as PHASER (Read 2001) was used to test twenty-five PDB models of interest, which also 
now included the models for benzaldehyde lyase ((BAL), 2AG0 and 2AG1). The structure of this 
enzyme was published (Mosbacher 2005) during the analysis with PHASER. PHASER utilizes 
more complex algorithms than AMoRe and also includes an iterative refinement process.   
The input for PHASER is much the same as for AMoRe, but the output is not in the form 
or Rf values and correlation coefficients but rather as Z-scores and log likelihood gain. Z-scores 
are defined as the likelihood that the result is correct. The magnitude of the Z-score is 
determined by the number of standard deviations the result is away from the mean of all results. 
A Z-score of eight or greater is said to indicate that phaser worked as a tool for MR, whereas a  
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Table 4.2 – Output results from AMoRe. The first column indicates the protein data bank model 
utilized for analysis. The second column provides the sequence identity of the protein in 
comparison to the MenD protein sequence. CC (2nd) refers to the best and second best result 
produced for correlation coefficient as produced by AMoRe. Rf (2nd) refers to the best and 
second best result for Rf values as produced by AMoRe. The PDB form indicates whether the 
coordinate file was for a dimer or tetramer. The following two columns are for the polyalanine 
models. The final column indicates the protein that is being analyzed.  
Model 
Used 
Seq. 
Identity 
CC 
(2nd) 
Rf 
(2nd) 
PDB 
form 
CC_Pala 
(2nd) 
Rf_Pala 
(2nd) Protein 
1PYD - 
9.4 
(9.3) 
55.1 
(55.0) tetramer 9.3 (9.2) 
55.4 
(55.4) 
Catalytic Centers of 
PDC 
1ZPD 27.273 
7.9 
(7.9) 
54.4 
(54.4) tetramer 
13.2 
(12.0) 
58.0 
(61.8) PDC from Z. Mobilis 
1N0H 
    
19.361 
7.3 
(7.3) 
54.6 
(54.7) dimer 8.3 (8.2) 
54.8 
(54.9) 
AHAS bound to 
Chlorimuron 
1T9A 19.361 
8.9 
(8.4) 
54.3 
(55.1) dimer 8.6 (8.5) 
54.7 
(54.9) 
AHAS bound to 
Tribenuron Methyl 
1T9B 19.361 
8.2 
(8.2) 
55.2 
(54.6) dimer 8.2 (8.1) 
55.3 
(55.7) 
AHAS bound to 
chlorsufuron 
1T9C 19.361 
8.4 
(8.4) 
54.6 
(54.6) dimer 8.4 (8.3) 
55.0 
(54.8) 
AHAS bound to 
Metsulfuron Methyl 
1T9D 19.361 
8.3 
(8.0) 
54.3 
(54.5) dimer 7.7 (7.7) 
54.5 
(54.6) 
AHAS bound to 
Sulfometuron  
1JSC 19.361 
9.0 
(8.9) 
54.4 
(54.6) dimer 8.4 (8.4) 
54.7 
(54.8) 
AHAS from S. 
Cerevesiae 
1OZG 18.891 
8.8 
(8.6) 
54.3 
(54.5) tetramer 8.3 (8.3) 
54.6 
(54.6) 
ALS tetramer with 
unusual intermediate 
1OZH 18.891 
8.4 
(8.3) 
54.4 
(54.6) dimer 8.3 (7.8) 
56.9 
(56.6) 
ALS dimer with unusual  
intermediate bound 
1OZF 18.891 
8.5 
(8.3) 
54.6 
(54.5) tetramer 8.0 (8.0) 
54.7 
(54.8) 
ALS from K. 
Pneumoniae 
1PO7 20.074 
8.7 
(8.6) 
54.5 
(54.7) tetramer 8.7 (8.6) 
54.5 
(54.6) BFD E28A mutant 
1Q6Z 20.074 
8.6 
(8.6) 
54.4 
(54.7) tetramer 8.5 (8.5) 
54.5 
(54.7) 
BFD E28A mutant with 
thiamine thiazoloone 
diphosphate bound 
1PI3 20.074 
9.0 
(8.8) 
54.5 
(54.5) tetramer 8.7 (8.7) 
54.3 
(54.5) E28Q mutant of BFD 
1BFD 20.074 
9.0 
(8.9) 
54.5 
(54.8) tetramer 8.8 (8.7) 
54.6 
(54.8) BFD from P. Putida  
1MCZ 20.074 error error tetramer Error Error 
BFD bound to R-
mandelate 
1OVM 29.167 
9.2 
(9.1) 
54.6 
(54.6) tetramer 
 9.0 
(9.0) 
54.6 
(54.8) IPDC from E. Cloacae 
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score below five indicates that it definitely did not work; intermediate values are less conclusive. 
LL-gain measures the difference of likelihood that the data can be predicted to match with your 
model than with a random distribution of the same atoms (Read 2001). 
Of the twenty-four models tested the best result was found with PHASER was the 
polyalanine model of benzaldehyde lyase (pAla-2AG0), which showed a Z-score of 10.34 and a 
LL-gain of +79.50. This was the only PDB file that produced a Z-score that exceeded eight 
(complete data in Table 4.2). Initial analysis using Refmac5 (Murshudov 1997) showed that the 
model produced had an Rf value of 52.1 and with stepwise refinement this was brought down to 
51.5 (refined model shown in Figure 4.1).  
However, despite continuous effort over several months to alter the alanine residues to 
that of the MenD sequence, and not seeing any positive results in the way of dropping Rf values, 
it was determined that the result was a false positive. It was shown to be highly model biased and 
was basically a duplicate of the benzaldehyde lyase polyalanine model. This was tested via a 
least squares superimposition using LSQMAN with the PHASER molecular replacement result 
and the polyalanine benzaldehyde lyase.  The result of this analysis was a root mean squared 
deviation (RMSD) of less than 0.01 Å. This indicates that benzaldehyde lyase and the pAla 
model that was produced by PHASER was essentially an exact replicate of benzaldehyde lyase. 
The results that were produced by PHASER encompassed several months of time to 
produce. The results led us to believe that the structure could and would be solved using 
molecular replacement strategies. However, it was found eventually that no means were 
available to solve the structure using PHASER. As such, other methods needed to be utilized.       
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Table 4.3 - Output results from PHASER. The first two columns of data indicate the output Z-
score and the value of log-likelihood gain following the rotation function. The next two columns 
displays the output Z-score and the value of log-likelihood gain following the translation 
function. The LL-gain refined indicates the log-likelihood gain following anisotropic corrections.   
PDB Search file 
Z-Score 
(RF) 
LL-gain 
(RF) 
Z-Score 
(TF) 
LL-Gain 
(TF) 
LL-gain 
refined 
Benzaldehyde Lyase (BAL)         
2AG0 (tetramer) 5.042 2.21 6.48 -154.05 -149.66 
2AG0 (monomer) 4.524 20.61 5.79 32.79 36.90 
2AG0 (polyAla) 5.829 40.17 10.04 76.31 79.50 
2AG1 4.994 2.81 6.68 -133.12 -145.80 
2AG1(polyAla) 4.913 30.90 7.41 25.68 40.78 
Benzoylformate Decarboxylase (BFD)       
1BFD (mono) 4.458 19.91 5.95 32.64 34.47 
1BFD (polyAla) 4.555 18.97 6.01 21.52 24.57 
Acetolactate Synthase (ALS)         
1OZF (dimer) 4.197 25.05 5.85 24.67 28.87 
1OZF (monomer) 4.939 21.89 5.84 32.72 38.41 
1OZF (polyAla) 5.155 30.81 5.28 42.84 43.33 
Pyruvate Decarboxylase from S. cerevisiae (ScPDC)      
1QPB (dimer) 4.556 23.63 6.00 24.58 22.08 
1PVD (dimer) 5.082 29.75 5.13 24.23 32.81 
1PVD (poly Ala) 4.987 27.21 5.07 29.83 33.45 
Pyruvate Decarboxylase Z. mobilis (ZmPDC)       
1PYD (dimer) 5.414 35.99 5.56 2.76 9.42 
1ZPD (tetramer) 4.418 -54.75 5.64 -397.11 x 
1ZPD (monomer) 4.787 23.12 5.78 35.57 40.65 
1ZPD (polyAla) 5.419 28.55 5.40 -73.26 -62.87 
Indolepyruvate Decarboxylase (IPDC)       
1OVM (tetramer) 4.754 -48.12 5.40 -425.96 -416.92 
1OVM 
(monomer) 4.693 28.04 5.81 36.28 43.35 
1OVM (polyAla) 5.025 25.73 5.47 -45.88 -41.85 
Acetohydroxy Acid Synthase (AHAS)       
1JSC (dimer) 5.069 35.08 6.03 39.44 41.24 
1JSC (monomer) 4.765 23.50 5.83 41.58 41.96 
1JSC (polyAla) 4.762 10.87 5.01 20.74 23.19 
1T9A (dimer) 5.060 25.40 6.39 20.31 28.49 
Theoretical Model       
1XV2  4.167 17.60 x x x 
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Figure 4.1 - PDB coordinate file produced by PHASER using 2AG0 polyalanine tetramer, Z-
score = 10.34, LL-gain (refined) = 79.50.  
4.1.5 Modeller 
 Since molecular replacement proved to be unsuccessful with models provided by the 
PDB it was thought that the generation of a model using the program Modeller (Fiser 2000) 
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could provide us with some insights into the orientation of the MenD active site and also provide 
an additional model to be tested for molecular replacement using PHASER.  
Modeller requires the user to provide an input PDB file and an input sequence alignment 
file. The sequence alignment file is composed of two proteins; the desired protein and that of the 
sequence of the associated input PDB. Based on the alignment, the structural implications of 
sequence, and the spatial restraints, a model of best fit containing the MenD sequence and the 
commonly observed ThDP dependent enzyme fold was generated. Given the results produced 
with PHASER, where a benzaldehyde lyase polyalanine model produced a Z-score greater than 
eight, it was presumed that the backbone structure of MenD and BAL were similar. As such, 
benzaldehyde lyase was utilized as the template for the MenD Modeller model.  
This generated model was then used as a search model for MR. This as well proved to be 
unsuccessful as the Z-score in PHASER was 5.02 and showed no gap between the top ten Z-
scores shown as results. As such the model (Figure 4.2) proved incapable of solving the phase 
problem.  
With the phase problem not able to be solved via molecular replacement, the Modeller 
model was analyzed in an attempt to gain understanding of MenD chemistry from the residues 
present within the active site and ThDP binding site (discussion in section 4.3). Binding of ThDP 
and substrates to ThDP-dependent enzymes requires a dimeric structure and the model produced 
by Modeller was only a monomer. Thusly, the program LSQMAN was utilized to produce a 
dimer by superimposing the Modeller model onto the A chain and C chain of benzaldehyde lyase 
to produce a tight dimer (Figure 4.3A). The generated AC MenD dimer model was then utilized 
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to iteratively produce a tetramer by superimposing it on the BD chain dimer of benzaldehyde 
lyase (Figure 4.3B). 
 
Figure 4.2 - Ribbon Diagram of monomer model produced by Modeller containing the MenD 
sequence; viewed in PyMol 
LSQMAN was also utilized to do a least square analysis as well to see how similar the 
Modeller model is to that of the PHASER polyalanine output result (Figure 4.1) and also to that 
of benzaldehyde lyase (Figure 1.14). The result of this analysis indicated an RMSD of 0.10 Å for 
both models. An RMSD of this magnitude shows that the models are almost identical. Also,  
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Figure 4.3 - A) generated dimer from the Modeller model B) generated tetramer from the 
Modeller model 
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alignment using PyMol shows that the supersecondary structure is almost identical and only the 
side chains differ when comparing benzaldehyde lyase (2AG0) to the Modeller model (Figure 
4.4). This indicates that no substantial spatial constraints were faced when generating the model 
with the MenD sequence in place of the BAL sequence.   
 
Figure 4.4 - Superimposition of MenD Modeller model tetramer (blue) and the PDB file 
produced by PHASER (red) in molecular replacement. Only notable difference is seen in the 
random loop of the middle domain seen at the top and bottom of the figure in red. LSQMAN 
reports RMSD = 0.10 Å  
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4.2 Expression of the MenD Gene   
4.2.1 Expression of MenD from pMD14b in BL21  
 Previous research done in the lab by Edyta Sieminska provided glycerol cells stocks of 
BL21 cells containing the pMD14b plasmid. Also, purified pMD14b plasmid that could be 
transformed into competent cells was also stored at -80 oC. However, upon attempting to express 
this gene from both the glycerol stocks of BL21’s and newly transformed BL21, Rosetta and 
DH5α cells, no major over-expression band was observed on an SDS-PAGE gel. (Figure 4.5A) 
Eventually, a transformed BL21 cell batch produced MenD protein (Figure 4.5B), but the 
concentration of MenD protein obtained within the soluble fraction was not sufficient for crystal 
screening to be done. The amount of protein that was expressed in the soluble fraction was less 
than 1 mg/L of media and other approaches for producing soluble MenD protein were 
investigated. 
4.2.2 Selection of a New Vector 
 The phase problem could not be solved with the 1.9 Å wild type data set collected and it 
was believed that further developments with the project could not be made with wild-type crystal 
diffraction. Therefore, a heavy atom derivative was desired in order to perform multiple 
wavelength anomalous dispersion (MAD) to solve the phase problem. The vector selected would 
be one that expressed SeMet proteins with high reliability. 
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Figure 4.5 - SDS-PAGE gel showing: A) Inadequate production of MenD protein in: 1A BL21 
glycerol stocks; 2A BL21; 3A Rosetta; 4A DH5α; marker B) Production of MenD protein from 
BL21 cells, 1-4B before lysis; 5B marker; 6-9B after lysis with lysozyme. The molecular weight 
for MenD is expected to be 61.4 KDa.  
 
A specific type of Qiagen vector known as pQE80L (Qiagen, Figure 4.6) was selected as 
the new target plasmid for the MenD gene to be cloned into. This plasmid provides various 
useful elements that were also present on pMD14b, including the same antibiotic selectable 
marker and an N-terminal hexa-histidine tag. The pQE80L plasmid contains a pair of lac 
repressors, making the expression of the protein more controlled, since expression of the target 
gene becomes completely dependent on the induction of the cells with IPTG (Qiagen 2003). 
Also, pQE80L can be expressed in a cloning strain and does not require purification and 
transformation of the plasmid into an expression strain such as BL21.   
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Figure 4.6 - Map of pQE80L as provided by Qiagen (Qiagen 2003) 
It was also thought that the use of pQE80L would allow for one of the large problems 
faced previously in the preparation of SeMet MenD protein to be overcome. Use of pMD14b 
resulted in leaky expression, meaning that protein was being expressed prior to the induction 
with IPTG and therefore wild-type (non-SeMet) protein was produced.  It was thought that the 
utilization of pQE80L will allow for complete inclusion of SeMet into the protein produced. 
4.2.3 Cloning of MenD gene into pQE80L 
 Primers capable of amplifying the MenD from purified pMD14b and also mutating the 
sequence such that a BamHI site was present upstream of the start codon and also a KpnI 
restriction site downstream of the stop codon were designed. This was done such that upon 
restriction digest of PCR product (containing the amplified MenD gene) and pQE80L with KpnI 
and BamHI (Figure 4.7), a subsequent ligation would result in the formation of the new plasmid 
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construct. Although several protocols were attempted, positive results were observed with the 
following experimental conditions: PCR amplification (annealing temperature 63 oC and 
annealing time 60 seconds, 30 cycles); restriction digestion (37 oC, 3 hours); ligation (25 oC 
(desktop/room temperature) 3 hours); transformation into Nova Blue cells via the heat shock 
method; and subsequent plating onto LB/agar plates. It may be noteworthy that the ligation 
required a far greater ratio of cut amplified product to cut plasmid then the suggested 3:1 ratio. 
Approximately one-hundred colonies were observed when the transformation was done on a 10:1 
ratio ligation mixture, but as the ratio was decreased fewer colonies were observed.  
 
Figure 4.7 - 10% Agarose gel with 1Kb Plus Marker (lane 1, Kb pairs shows beside) and PCR 
amplified MenD gene following a) single digest with BamHI, b) single digest with KpnI, c) 
double digest. The experiment shows that the target gene (1.7 Kb pairs) was cut as intended and 
did not contain internal KpnI or BamHI sites as was expected  
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The resultant colonies that grew on the plates could have been pQE80L that had re-
annealed to itself or pQE80L fused with our cut DNA insert of interest. Since both would confer 
ampicillin resistance, both could allow colonies to grow on the plate. As such, a colony PCR 
experiment was performed on each single colony formed on the plates. The colony PCR 
experiment utilized an almost identical procedure to that of the initial PCR experiment. Positive 
inclusion of the MenD gene into the pQE80L plasmid was indicated with a 1700 base pair band 
visualized using agarose gel electrophoresis. The band size can be measured by being compared 
to 1 Kb Plus marker.   
4.2.4 Expression of MenD from pQE80L Construct 
 MenD protein was expressed from the new construct within Nova Blue cells. This was 
accomplished by inducing the cell grown in 1.0 L of LB with 0.4 mM IPTG at OD600 equal to 
0.4. A protein band viewed on an SDS-PAGE gel (Figure 4.8, lane 4) confirmed the over-
expressed protein shared similar size to that seen with pMD14b expressed protein (Figure 4.5). 
Nearly twenty milligrams of over-expressed protein were recovered following purification, 
dialysis and concentration of protein. Resultant SDS-PAGE gel following expression and 
purification is seen in Figure 4.8 (land 2 and 3).  The purification, dialysis and concentration 
process was the same that was followed with pMD14b plasmid expressed protein as described in 
materials and methods.  
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Figure 4.8 - SDS-PAGE Gel: Lane 1 – marker, Lane 2 - 3µL of concentrated and purified 
protein, Lane 3 – 10µL of concentrated and purified protein, Lane 4 – unpurified soluble 
fraction, Lane 5 – insoluble pellet protein 
4.2.5 Testing Purified Protein for MenD Activity  
 The protein sample obtained was then tested for MenD reaction activity to prove the new 
construct was a functional MenD enzyme. This was done using a coupled assay which utilizes 
lactate dehydrogenase, NADH and pyruvate, which was previously believed to be a product of 
the MenD reaction. This assay allows for the progress of the MenD reaction to be monitored 
with decrease absorption of 340 nm light. NADH, which has an absorption peak at 340 nm, is 
reacted to produce NAD+ as pyruvate is evolved and utilized as a substrate for lactate 
dehydrogenase (Figure 4.9). Protein expressed from the new construct (which was called 
pMD80L), indicated a Vmax value of 0.97 µM/min when an enzyme concentration of 90 nM was 
utilized. This result was comparable to that of the pMD14b enzyme of the same concentration 
(1.0 ± 0.3 µM/min) (Ho 2007).  
Additional research was done by Maohai Fang utilizing the new methods for MenD 
kinetic analysis with SEPHCHC as the product (Jiang 2007). MenD from pMD80L was found to 
have a kcat value of 18 ± 2 min-1. This result was comparable to the kcat value of 4.5 ± 0.4 min-1 
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published for MenD (Jiang 2007). These kinetic results confirm that cloning procedures were 
successful and the protein expressed from the gene cloned into pQE80L is MenD.   
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Figure 4.9 - Lactate dehydrogenase assay for monitoring MenD Activity. The spontaneous 
production of SHCHC from SEPHCHC produces pyruvate which is then converted to lactate by 
lactate dyhydrogenase (LDH). The reaction with LDH results in the oxidation of NADH to 
NAD+ and thusly causes a loss in absorption at 340nm within the reaction mixture. The rate of 
reaction is determined by the rate of decrease in absorption at 340nm. 
4.2.6 Crystal Trials and diffraction of Native pMD80L protein 
The Nextal crystal screen suites provided by Qiagen were used for initial screening. All 
screens (both microbatch and sitting drop technique) were tested with 20 mg/mL protein 
concentration. Analysis of the crystal plates showed that nearly seventy percent of the wells 
contained precipitate and no crystals were discovered. As such, the concentration was halved to 
10 mg/mL. Upon setting up the screens with this concentration of protein a reduced number of 
precipitation events occurred but still no protein crystals were found.  
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Next, all contents of the dialysis buffer were removed except for the 50 mM Tris-HCl pH 
7.8 and the cofactors ThDP and Mn2+. The dialysis buffer utilized was designed for pMD14b 
construct to decrease occurrence of protein precipitation upon dialysis and concentration. It was 
found that removal of 12.5% glycerol and 200 mM NaCl had no effect on protein solubility with 
pMD80L. These two contents could potentially have hindered the crystallization process by 
acting like contaminants which prevented ideal protein-protein interactions. 
Upon re-screening with the protein dialyzed (three-fold dialysis) into only 50 mM Tris-
HCl pH 7.8 and the cofactors many conditions were found to produce crystals. Those conditions 
that produced crystals via the sitting drop method are listed in Table 4.4. All of the conditions 
listed were tested on the in-house Proteum diffractometer. The results of the diffraction 
experiments produced some results worthy of mention and are included in Table 4.4 as well. It 
became noticeable that the conditions containing a buffer (Tris / HEPES) with pH between seven 
and eight, and MPD with concentrations 30% to 50% weight- to-volume ratio, produced crystals 
that showed some diffraction. The listing of the result ‘diffraction’ is indicative of just a few 
protein spots present on the diffraction image with resolution being approximately 6-15 Å in 
most cases. An example of crystals that showed diffraction is shown in Figure 4.10. 
Optimization of the HEPES buffer (pH 7.0, 7.5, 8.0, 8.5) and TRIS buffers (pH 7.0, 7.5, 
8.0, 8.5) was done in varying concentrations of MPD (0%, 5%, 10%,…50%, 55% (w/v)). From 
this analysis it was found that far more crystals were obtained in the pH 7.5 HEPES buffer then 
in all of the other HEPES and Tris conditions combined. A second optimization screen was then 
done with 0.1 M HEPES buffer pH 7.5 that added PEG4000 to solution (2.5%, 5%, 7.5%, 10% 
PEG4000) to six different MPD conditions (25%, 27.5%, 30%, 32.5%, 35%) in the first forty-
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eight wells, and the same conditions in the absence of PEG4000 in the other forty-eight wells. 
Crystals were produced overnight in 35% MPD, 7.5% PEG4000 and 0.1 M HEPES buffer pH 
7.5 (Figure 4.11). It was also found with more testing that this result was reproducible and could 
also be done successfully via the hanging drop method as well. Hanging drop experiments were 
done with 5 µL of protein solution and 5 µL of well solution, leaving 995 µL in the well. Results 
showed that the hanging drop method produced parallel results to that of the sitting drop method; 
however, larger crystals were produced with the hanging drop methods (Figure 4.12). 
Table 4.4 - Crystallization conditions that produced crystals at [protein] of 10mg/mL and 
diffraction results from the in-house DX8 Proteum diffractometer.  
Crystal Screen / well Crystal condition diffraction 
ComPAS D1 0.1 M TRIS pH 8.5, 10 %(w/v) Ethanol none 
ComPAS E1  0.1 M HEPES pH 7.5, 5 %(w/v) Isopropanol none 
ComPAS E5 0.05 M Sodium chloride, 0.1 M TRIS pH 8.5, 12 %(w/v) Isopropanol salt  
ComPAS E6 0.2 M Sodium citrate, 0.1 M MES pH 6.5, 15 %(w/v) Isopropanol salt 
JCSG+ D1 24 %(w/v) PEG 1500, 20% (w/v) Glycerol none 
JSCG+ D5 0.1 M HEPES pH 7.5, 70 %(v/v) MPD diffraction 
JCSG+ D6 0.2 M Magnesium chloride, 0.1 M TRIS pH 8.5, 20 %(w/v) PEG 8000 none 
JCSG+ D7 0.2 M Lithium sulfate, 0.1 M TRIS pH 8.5, 40 %(v/v) PEG 400 none 
Cryos B3  0.018 M Calcium chloride, 0.09 M Sodium acetate pH 4.6, 27 %(v/v) MPD salt 
Classics C3 0.1 M TRIS.HCl pH 8.5, 2.0 M Ammonium phosphate salt ring 
Classics B10 0.1 M HEPES pH 7.5, 70 %(v/v) MPD diffraction 
Classics Lite C10 0.2M K/Na tartrate, 0.1M tri-Na citrate pH 5.6, 1M NH4+ sulfate salt/ice ring 
Classics2 C2 1.1 M Ammonium tartrate pH 7.0 salt/ice ring 
MPD F10 0.1 M TRIS pH 8.0, 65 % (v/v) MPD none 
MPD F11 0.1 M TRIS pH 8.0, 65 % (v/v) MPD none 
MPD H4 0.1 M HEPES pH 7.5, 30 % (w/v) MPD, 5% w/v PEG4K diffraction 
MPD H5 0.1 M Imidazole.HCl pH 8.0, 30 % (w/v) MPD diffraction 
MPD H6 30 %(w/v) MPD, 20 %(w/v) Ethanol none 
MPD H10 0.1 M HEPES sodium salt pH 7.5, 47 %(w/v) MPD diffraction 
MPD H11 47 %(w/v) MPD, 2 %(w/v) tert-Butanol none 
MPD H12 50 %(w/v) MPD diffraction 
 
 Figure 4.10 - Photograph of crystals within well 88 (H4) in the MPD screen. The largest of the 
three crystals (bottom left) measures 0.21
Figure 4.11 - Photograph of 
and 0.1M HEPES buffer pH 7.5) in a sitting drop well. The crystal with a star next to it measures 
0.34 mm x 0.068 mm x 0.068 
 mm x 0.07 mm x 0.07 mm 
Optimized Crystallization condition (35% MPD, 7.5% PEG4000 
mm. 
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 Figure 4.12 - Photograph of Hanging Drop Crystallization condition (35% MPD, 7.5% 
PEG4000 and 0.1M HEPES buffer pH 7.5) A protein film is noticeable in this picture because 
the photo was taken following exposure to open air to collect crystals for diffraction. Crystal 
with a red star beside it measures 0.51
 The crystals produced in the optimized condition were diffracted at the APS in Chicago. 
The result of this diffraction was an incomplete data set with diffraction near 2.5 Å. The detected 
diffraction signal was not an improvement on previous native crystals which were 
However, the key result is that the crystals 
pMD80L construct diffracted at a resolution that was below 3.0 Å
sufficient for utilization with M
methionine.    
4.2.7 Growth of pMD80L in Minimal Media
 MenD protein from the pMD80L construct 
in minimal media containing methionine, not SeMet. A brief search of various protocols fo
SeMet expression yielded six separate protocols with slightly varied reagents for carbon and 
 mm x 0.11 mm x 0.11 mm.  
grown utilizing the protein produced from the 
. This resolution 
AD phasing if the crystals contained SeMet
   
was then expressed in Nova Blue c
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diffracted. 
would be 
 rather than 
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nitrogen sources. Some of the preparations also involved the inclusion of the other nineteen 
amino acids and/or the four nucleotides as well. Of the six protocols, the successful protocol for 
expressing soluble MenD in minimal media was the condition that included both nucleotides and 
the amino acids in the mixture (Hendrickson 1990).  Prior to induction with IPTG there is almost 
no expression of any protein, however upon induction the protein of interest is expressed but also 
appears to be the only protein being expressed within the soluble fraction (Figure 4.13).  
 
Figure 4.13 - Expression of MenD from pMD80L within minimal media A) SDS-PAGE gel 
showing no protein production prior to induction with IPTG. B) SDS-PAGE gel of three 
identical preparations following IPTG induction, harvesting, sonication and lysis of cells but not 
yet purified. Lane 4B contains cellular pellet showing insoluble protein and Lane 5A/5B are low 
molecular weight selectable marker.  
4.2.8 Purification of MenD from pMD80L in Presence of TCEP  
 The protein sample acquired from the minimal media preparation was then purified using 
a nickel chelating column that is utilized to purify histidine tagged proteins. The procedure was 
intended to show that SeMet protein can be purified using a similar procedure to that of native 
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protein. The only difference between the two procedures is the presence of 0.2 mM TCEP in all 
of the buffers utilized to bind, wash and elute the column. TCEP is a reducing agent that 
stabilizes SeMet protein in solution and also does not reduce the nickel metal ions on the 
chelating column. (Bergendahl 2002) The results of the purification in the presence of TCEP (Figure 
4.15) were very similar to that of the results seen in the absence of TCEP (Figure 4.14). From 
this result it is expected that SeMet protein will be able to be purified using the same procedure 
used with the native protein.  
4.2.9 Expression of SeMet Protein from the pMD80L construct 
 A single SeMet preparation was done utilizing a high yield 12-L SeMet preparation kit, 
which had proven to be very successful for other proteins within the lab. The growth of cells 
within this medium was far slower than in any other expression preparation. In order for the 
cultures to grow and reach an OD600 value above 0.3 a quantity of cells estimated to be more than 
ten times the quantity of cells used in any other preparation was required. The time period for 
this level of growth to occur exceeded twenty-four hours, however, once the log phase of growth 
was entered the bacterial cells behaved similarly to that of cells within LB media.  Induction with 
IPTG took place at OD600 equal to 0.4, as was done previously. The cells were grown for an 
additional eight hours, rather than the standard four hours. Despite the extra time given, a smaller 
quantity of cells was collected from the 1.0 L culture than was often collected in a 100 mL 
culture in LB media. The His-tag purification procedure also shows a smaller peak in the elution 
stage then in other analyses, but was nonetheless still present (Figure 4.16).    
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Figure 4.14 - Output chromatogram of purification of protein from pMD80L plasmid; Note the 
magnitude of the peak A280 in the stepwise gradient elution reaches nearly 0.4. Protein was 
injected onto the column at 0 and 5 minutes. The wash buffer began at 8 minutes and the elution 
buffer gradient began just before 10 minutes.  
 
Figure 4.15 - Output chromatogram of purification of protein from pMD80L plasmid in the 
presence of 2 mM TCEP; protein sample used was identical to the sample used to produce Figure 
4.11. Protein was injected onto the column at 0 and 5 minutes. The wash buffer began at 8 
minutes and the elution buffer gradient began just before 10 minutes.  
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 Upon analysis with UV/Vis spectroscopy at 280 nm it was found that there was 9.6 mg of 
protein produced from the expression using the kit. However, upon undergoing dialysis the 
protein precipitated.  The exact reason that this occurred is not understood but it is possible that 
the concentration of TCEP added to the dialysis buffer was inadequate. The sample was then 
filtered and concentrated and protein concentration measured again. It was found that less than 
1.0 mg of protein was found in the remaining 2 mL of sample.  
 
Figure 4.16 - Output chromatogram of purification of SeMet protein from pMD80L plasmid in 
the presence of 2 mM TCEP Protein was injected onto the column at 0 and 5 minutes. The wash 
buffer began at 8 minutes and the elution buffer gradient began just before 10 minutes. 
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4.2.10 Crystal Trials of SeMet pMD80L Protein 
 With the limited volume of SeMet protein remaining and the low concentration found 
(1.0 mg/mL), crystal trials were attempted with what was produced from the expression 
procedure. The concentration of protein was approximately 1.0 mg/mL, about one tenth of what 
was used when crystals were produced in native protein. The condition used was the same as was 
used for optimized native protein crystal trials (35% (w/v) MPD, 7.5% PEG4K and 0.1 M 
HEPES pH 7.5) with the addition of 4 mM TCEP to the well solution, such that the final 
concentration of TCEP in the drop would be maintained at 2 mM. The sitting drop technique was 
used with 1 µL of protein to 1 µL of precipitant within the drop. The result of this was no SeMet 
crystals; likely due to the low protein concentration.  
4.3 Structure-Based Sequence Alignment of ThDP-Dependent Enzymes 
4.3.1 Structure-based sequence alignment of ThDP-Dependent Enzymes using BAL (2AG0) 
as the Search Model 
A structure based sequence alignment was completed on the enzymes within the DC family 
using BAL as the search model in an attempt to enhance our understanding of the similarities and 
differences between these enzymes. The online program FUGUE (Shi 2001) was used to perform 
the alignment and the format displayed is an output from the online program ESPript (Gouet 
1999). The result is seen below in Figure 4.17. The focus of the discussion will be on variations 
that exist between the enzymes within the family in respect to key residues and sequences. 
Among these include the glutamate residues in the Pyr domain responsible for the activation of 
ThDP and the GDG-X24-NN binding motif, which is responsible for Mg2+ binding and ThDP 
binding.  
79 
 
 The glutamate residue that is thought to be responsible for ThDP to be activated, and 
form the ylide is said to be invariant (Frank 2007). Identified on the sequence alignment with a        
it becomes noticeable that the glutamate is conserved across all ThDP enzymes. The results are 
in agreement with the research done previously with ThDP dependent enzymes.  
The GDG-X24-NN binding motif, which is responsible for Mg2+ binding and ThDP 
binding, is highly conserved within the ThDP dependent enzymes but is not invariant. The motif 
is conserved in benzaldehyde lyase (BAL, PDB code: 2AG0) (Mosbacher 2005), indolepyruvate 
decarboxylase (IPDC, PDB code: 1OVM) (Schutz 2003), benzoylformate decarboxylase (BFD, 
PDB code: 1BFD) (Hasson 1998), carboxyethyl arginine synthase (CEAS, PDB code: 1UPA) 
(Caines 2003), pyruvate decarboxylase from Zymomonas mobilis (ZPDC, PDB code: 1ZPD) 
(Dobritzsch 1998) and pyruvate decarboxylase from Saccharomyces cerevisiae (YPDC, PDB 
code: 1PVD) (Arjunan 1996).  
For acetohydroxy acid synthase (AHAS, PDB code: 1JSC), the ThDP binding motif is 
slightly altered to GDA-X24-NN. The mutation of the glycine to an alanine is a conservative 
mutation. Also, considering that the residue side chain is not involved in binding of ThDP or 
Mg2+, but rather the main chain oxygen, the mutation is rather insignificant.  
The sequence of oxalyl-CoA decarboxylase (OCDC, PDB code: 2JIB) also indicates a 
discrepancy within the common GDG-X24-NN motif that is present for binding of ThDP and the 
magnesium ion.  Instead there is a GDS-X24-NN present within the sequence of OCDC. 
However, once again this seems like a relatively minute alteration to the enzyme binding site of 
ThDP since it is the main chain carbonyl of that residue that contributes to binding and not the 
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side chain itself. The serine residue is larger spatially then glycine which is commonly seen or 
alanine as is present within AHAS. However, analysis of the residues present within AHAS, 
BAL and OCDC indicates the side chains and main chain oxygen are oriented similarly.  
The sequence of pyruvate oxidase (POX, PDB code: 1POX) has a slight alteration to the 
GDG-X24-NN binding motif to GDG-X24-TN.  The exchange of the asparagine residue to a 
threonine is again a conservative alteration to the motif since only the second asparagine residue 
is involved in Mg2+ binding within POX. The motif was referred to as GDG-X25-N within the 
POX research article (Muller 1993).  This was the convention at the time for displaying the motif 
since the first three models within the family of ThDP enzymes (POX, ScPDC and the model of 
transketolase) do not share alignment of the second asparagines residue. Muller’s article also 
states that the glutamine (Gln476) adjacent to Asn474 within the motif, contributes to the Mg2+ 
binding. This contribution is filled by the second asparagine residue within the rest of the ThDP 
dependent enzyme family. 
As stated within the introduction section acetolactate synthase (ALS) does not contain the 
asparagine portion of the GDG-(X24)-NN motif that is conserved for binding of ThDP and Mg2+. 
This is clearly observed in the structure based sequence alignment of the ThDP dependent 
enzymes (Figure 4.17). It is notable that this is the only enzyme within the family that does not 
contain GDG-(X25)-N motif. The discussion of this alteration (Pang 2004) mentions that the 
aspartate side chain oxygen (Asp474) and the backbone oxygen of Gly476 contribute to the 
binding of the diphosphate within the PP domain in the stead of the common NN motif.  
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Figure 4.17 - Structure based sequence alignment of the DC family with benzaldehyde lyase as 
the structural search model 
4.3.2 Structure-Based Sequence Alignment with MenD Modeller Model 
 A structure-based sequence alignment can be used to evaluate the validity of a theoretical 
model since it takes into account both the secondary structure features as well as the primary 
sequence features. If the MenD Modeller model were to show no discrepancy in the alignment of 
the key elements of the ThDP dependent enzymes binding motifs and conserved residues then 
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perhaps some determination could be made in regards to the shape of the active site, the 
determination of catalytically contributing residues and the binding of ThDP and Mg2+. 
 The structure based sequence alignment of the Modeller model produced mixed results 
(Figure 4.18). When compared to the result of Figure 4.17, it is notable immediately that the 
invariant glutamate no longer is aligned amongst the entire list of enzymes. This could most 
likely be improved with a small manual alteration to the alignment of POX, since the glutamate 
required for invariant alignment is only one residue to the right. It was thought it was possible 
that the glutamate in POX was not the first residue in the alpha helix, as is the case for the rest of 
the enzymes, but analysis (Figure 4.19) indicates that this is not the case.  
To confirm that the conserved glutamate was in the proper orientation within the model, 
ThDP from benzaldehyde lyase was superimposed into the ThDP binding site. The 
superimposition of ThDP shows that Glu55 within MenD is in fact in the orientation expected 
(Figure 4.20). Furthermore, there appears to be an arrangement of charged residues between the 
pair of active sites that may be indicative of a 20 Å tunnel that allows for catalytic duality (as 
seen in Figure 1.11) and non-equivalent active sites (Figure 4.21).   
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Figure 4.18 - Structure based sequence alignment of the DC family with the MenD Modeller 
model as the search model. It is important to note that the sequence number listed at the top of 
each segment indicates the amino acid number minus one. This is due to the lack of methionine 
at the beginning of the sequence. For example the invariant Glu55 of MenD would appear to be 
numbered 54 in this figure.  
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Figure 4.19 - Analysis of the 1POX model to ensure Glu59 is the first residue in the alpha helix 
as is the tendency for the invariant glutamate residue in ThDP-dependent enzymes. 
 
Figure 4.20 - Location of Glu55 within the MenD Modeller Model. The distance from the 
carboxyl group of glutamate to the N1´ atom of the pyrimidine is 4.1 Å (measured with Coot) 
which is slightly out of range for hydrogen bonding. The orientation is as was expected though.    
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Figure 4.21 - The 18.83 Å tunnel between the two active sites within one of the dimer pairs of 
the MenD Modeller model. The charged residues between the pair of active sites may form a 
hydrogen bonding bridge that explains the non-equivalence of active sites often seen in ThDP-
dependent enzymes (Figure 1.11).  
 
 The alignment of the GDG-(X24)-NN motif using the MenD Modeller model remains the 
same as it was for the alignment using 2AG0. However, alignment of the MenD structure 
indicates that the GDG portion is not conserved similar to that of OCDC and AHAS. The 
implication is similar as it would be assumed that the backbone oxygen atom would contribute to 
binding and that the GDL sequence seen in MenD would have no implication on binding. The 
assumption is made that the large leucine residue will not point into the ThDP binding site but 
rather into the interior of the protein as was the case for the serine in OCDC (2JIB). Upon 
analysis (Figure 4.22) it is shown that Leu443 runs along the edge of the ThDP biding site and 
may contribute to induction of the V-conformation of ThDP upon binding. In most ThDP 
dependent enzymes, the main chain oxygen contributes to diphosphate binding; however this 
does not seem to be possible in the Modeller model since the main chain oxygen points away 
from the diphosphate. It is indeed possible that this unique sequence difference in MenD when 
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compared to other ThDP-dependent enzymes has an alternative role for ThDP binding and 
activation.  
As was stated in the introduction, previous research done in our lab has implicated Ile418 
as the residue responsible for the induction of the V-conformation of ThDP. Identification of this 
residue within the model was also done (Figure 4.23) and it shows that within the model this 
residue has no role in the binding of ThDP. This result is indicative that either the Modeller 
model is incorrect or that Ile418 has a very important internal structural role for MenD since 
mutagenesis of this residue results in significant loss in enzyme activity. 
There are various other residues that have been implicated via mutagenesis studies to be 
contributing residues of catalysis of the MenD reaction. Among these is Asp442, which was 
implicated for Mg2+ binding. The MenD Modeller model shows this residue to be in direct 
proximity of the ThDP moiety (Figure 4.24). Also, Figure 4.24 and the structure based sequence 
alignment indicate that Asp442 is part of the GDL-X24-N binding motif.    
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Figure 4.22 - Location of Leu443 within the MenD Modeller model; Note the orientation that 
runs along the edge of the ThDP binding pocket.  
 
Figure 4.23 - Location of Ile418 within the MenD Modeller Model; Note the location is not in 
close proximity to the cofactor ThDP.  
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Figure 4.24 - Location of Asp442 within the MenD Modeller Model; Note the orientation that 
runs directly adjacent to the diphosphate and can be assumed to be in close proximity to the 
Mg2+ cofactor. Also note the presence of the remainder of the GDL-X24-NN binding motif within 
this figure and how all of these residues are in direct proximity to the diphosphate of ThDP 
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4.3.3 MenD Modeller Model Active Site Residue Analysis 
 In addition to the residues that  have been discussed thus far, a variety of other residues 
within MenD have been investigated with mutagenesis studies including Ser32, Arg33, Arg395, 
Gln118 which were all thought to participate in catalysis. Upon analysis of the MenD Modeller 
model it was found that these results were in agreement with the model with the exception of 
Arg395. Ser32, Arg33 and Gln118 point directly into the active site and are directly adjacent to 
the C2 position of the thiazolium ring (Figure 4.25) Although Arg395 is adjacent to the active 
site it is too far from C2 of the thiazolium ring to make the conclusion that it participates in 
catalysis. Along with Ser32, Arg33 and Gln118, the model indicates that the active site is also 
formed by Leu478 and Asn117 (also in Figure 4.25). These results are indicative of the validity 
of previous mutagenesis studies done within the Palmer laboratory (Macova 2005, Ho 2007). 
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Figure 4.25 - The MenD active site residues according to the MenD Modeller Model; Residues 
thought to be capable of participating in catalysis/binding of substrate include (but are not 
limited to) Asn117, Gln118, Ser32, Arg33 and Leu478.  
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Chapter 5: 
Concluding Statements and Summary 
The results described in this thesis have provided the research project with a variety of 
contributions. The data set collected in 2005 was processed and it was determined that the 
holoenzyme data set was more suitable for molecular replacement strategies. It was shown that 
with the current models listed within the protein data bank, the use of molecular replacement is 
not a reasonable means to solve the phase problem for MenD with this data. A variety of 
software packages including MRBUMP, AMoRE and PHASER were utilized to achieve this 
task but none were successful. The final attempt to solve the phase problem via molecular 
replacement was done by generating a model of MenD with the program Modeller. Although this 
strategy was also unsuccessful in solving the phase problem for the holoenzyme data set, the 
model developed provides the opportunity to make a variety of implications in regards to the 
structure function relationship of MenD and the binding of ThDP.   
 With the results from the computational efforts with the data set provided it was 
necessary to develop a new system for producing SeMet MenD protein. This system was 
developed by cloning the MenD gene into a new plasmid (pQE80L), which was ideal to produce 
SeMet protein to be utilized for MAD phasing. The resulting plasmid construct (named 
pMD80L) was able to express active MenD enzyme, in both LB broth and minimal media. It was 
also possible to utilize previous methods of purification with pMD14b in the presence of TCEP 
to purify protein produced from pMD80L. Native crystallization conditions for pMD80L protein 
were determined and the crystals diffracted to 2.5 Å at the Advanced Photon Source in Chicago. 
SeMet protein was expressed with a SeMet kit, however, inclusion of SeMet was not confirmed.  
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Future work done on this project should focus on the expression, purification and 
crystallization of the SeMet derivative of MenD from pQE80L. The major project goal to solve 
the phase problem and produce an accurate model of MenD that could be submitted to the 
protein data bank was not completed. However, many steps have been made to make completion 
of this goal a reality in the near future. Further optimization of the crystal conditions may be 
necessary to produce diffraction quality crystals for the SeMet derivative protein. Although, if a 
MAD data set of less than 3.0 Å is produced the phase problem should be able to be solved. With 
the 1.9 Å holoenzyme data set already processed, a high resolution structure of MenD is 
achievable in the near future for this lab group.  
______________________________________________________________________________ 
During the preparation of this thesis the structure of MenD was published by a group 
from The University of Dundee in Scotland in the Journal of Molecular Biology (Dawson 2008). 
The structure was solved via single wavelength anomolous dispersion (SAD) phasing at 2.8 Å 
resolution using a SeMet derivative. The structural model was then improved to 2.5 Å using 
molecular replacement with a native data set.  
The structure shows the general ThDP-dependent enzyme architecture with the three 
domains, each consisting of six parallel β-sheets sandwiched between several α-helices in an α/β 
supersecondary structural motif (compared to Modeller model in Figure 5.1). MenD was 
confirmed to be part of the DC family of enzymes and was shown to be most structurally similar 
to benzoylformate decarboxylase (Cα-RMSD = 2.54 Å) and oxalyl-CoA decarboxylase (Cα-
RMSD = 2.56 Å). 
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Figure 5.1 – The structural model of MenD (gold) superimposed over the Modeller model 
(blue). ThDP is shown as a stick model in pink. Noticeable differences are seen between the two 
models, specifically in the middle domain where the six parallel β-sheets do not overlap.  
Several discrepancies are now seen in the Modeller model discussed in this thesis. The 
structural differences are viewed with the superimposition of the six parallel β-sheets within the 
middle domain and a variety of  α-helices throughout the structure (Figure 5.1). Furthermore, the 
induction of the V-conformation is in fact caused by Ile418 (Figure 5.2) as was assumed from 
mutagenesis studies (Ho 2007) but could not be confirmed with the Modeller model (Figure 
4.23).  
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Figure 5.2 – Location of both Ile418 and Leu443 in the MenD model. This indicates that the V-
conformation is induced by Ile418 and not Leu443. 
Finally, significant differences are seen for the active site residues implicated to 
participate in substrate binding and catalysis (Figure 4.24).  Upon analysis of the structure of 
MenD (Dawson 2008), it is notable that the catalytic residues implicated by the Palmer 
laboratory (namely Ser32, Asn117 and Gln118) are indeed present within the active site cleft 
(Figure 5.3) and could participate in catalysis. However, the majority of the active site is 
composed of basic arginine, lysine and asparagine residues that aid in the binding of MenD’s 
acidic substrates, isochorismate and 2-ketoglutarate. Ile474, Phe475, and Leu478 are also present 
within the active site and are implicated in binding of the hydrophobic portion of isochorismate. 
Despite several differences, there are certainly similarities seen when comparing the 
Modeller model to the structure of MenD. For instance, when comparing the locations and 
conformations of the residues involved in the ThDP-binding motif GDL-(X24)-NN for the  
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Figure 5.3 – The active site of MenD. Arg33, Arg107, Lys292 and Arg295 aid in the binding of 
MenD’s acidic substrates, isochorismate and 2-ketoglutarate. Hydrophobic contacts are made 
with the hydrophobic ring of isochorismate by Ile474, Phe475, and Leu478. Note that the active 
site is formed from a dimer, monomer A is shown in green and monomer B is shown in light 
blue. 
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structure of MenD (Figure 5.4) to that presented for Modeller model (Figure 4.24) they are 
almost identical. The structure of MenD also shows similar orientation of the residues implicated 
to form the 20 Å catalytic duality tunnel that shuttles a proton between the pair of active sites 
(Figure 5.5) to that seen in the Modeller model. However, the residues Asp54, Glu55, Arg56 and 
Tyr447 are thought to block access between the two active sites preventing the transfer of a 
proton (Dawson 2008).  
 
 
Figure 5.4 – ThDP-binding motif GDL-(X24)-NN within the MenD structure.  
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Figure 5.5 – The absence of a catalytic duality tunnel in the structural model of MenD. The 
residues Asp54, Glu55, Arg56 and Tyr447 block access between the two active sites. 
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